UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐ | Preliminary Proxy Statement |
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☒ | Definitive Proxy Statement |
☐ | Definitive Additional Materials |
☐ | Soliciting Material Pursuant to §240.14a-12 |
The Procter & Gamble Company
(Name of Registrant as Specified In Its Charter)
Payment of Filing Fee (Check the appropriate box):
☒ | No fee required. |
☐ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
(1) | Title of each class of securities to which the transaction applies: |
(2) | Aggregate number of securities to which the transaction applies: |
(3) | Per unit price or other underlying value of the transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): |
(4) | Proposed maximum aggregate value of the transaction: |
(5) | Total fee paid: |
☐ | Fee paid previously with preliminary materials. |
☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
(1) | Amount Previously Paid: |
(2) | Form, Schedule or Registration Statement No.: |
(3) | Filing Party: |
(4) | Date Filed: |
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
August 23, 2019
Fellow Procter & Gamble Shareholders:
It is our pleasure to invite you to this years annual meeting of shareholders. The meeting will take place on Tuesday, October 8, 2019, at 9:00 a.m. Eastern Daylight Time at The Procter & Gamble Company General Offices, 1 Procter & Gamble Plaza, Cincinnati, Ohio 45202. At the meeting, our shareholders will be asked to:
☑ | Elect the 12 Director nominees listed in the accompanying proxy statement; |
☑ | Ratify the appointment of the independent registered public accounting firm; |
☑ | Approve, on an advisory basis, the Companys executive compensation (the Say on Pay vote); |
☑ | Approve The Procter & Gamble 2019 Stock and Incentive Compensation Plan; and |
☑ | Transact such other business as may properly come before the meeting. |
Shareholders of record as of the close of business on August 9, 2019 (the record date) are entitled to vote at the annual meeting and any postponement or adjournment thereof. Please see pages 2-5 for additional information regarding admission to the meeting and how to vote your shares. If you plan to attend the meeting in person, we encourage you to register for admission by Monday, October 7. If you are not able to attend the meeting in person, you may join a live webcast of the meeting on the Internet by visiting www.pginvestor.com at 9:00 a.m. Eastern Daylight Time on October 8.
Your vote is important. Please vote your proxy promptly to ensure your shares are properly represented, even if you plan to attend the annual meeting. You can vote by Internet, by telephone, or by requesting a printed copy of the proxy materials and using the enclosed proxy card.
We appreciate your continued confidence in our Company and look forward to seeing you at The Procter & Gamble Company General Offices on October 8, 2019.
|
![]() | |
DAVID S. TAYLOR CHAIRMAN OF THE BOARD, PRESIDENT AND CHIEF EXECUTIVE OFFICER |
DEBORAH P. MAJORAS CHIEF LEGAL OFFICER AND SECRETARY |
REVIEW THE PROXY STATEMENT AND VOTE IN ONE OF FOUR WAYS:
![]() |
VIA THE INTERNET Visit www.proxyvote.com. |
![]() |
BY MAIL Sign, date, and return the enclosed proxy card or voting instruction form. | |||
|
BY TELEPHONE Call the telephone number on your proxy card, voting instruction form, or notice. |
|
IN PERSON Attend the annual meeting in Cincinnati. See page 4 for additional details on how to preregister. |
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Shareholders to be held on October 8, 2019: This Notice of Annual Meeting, the Proxy Statement, and the 2019 Annual Report are available at www.proxyvote.com.
TABLE OF CONTENTS | ||
i | ||
1 | ||
2 | ||
6 | ||
6 | ||
16 | ||
28 | ||
30 | ||
31 | ||
47 | ||
47 | ||
50 | ||
52 | ||
55 | ||
56 | ||
58 | ||
62 | ||
64 | ||
65 | ||
69 | ||
70 | ||
72 | ||
Item 2. Proposal to Ratify Appointment of the Independent Registered Public Accounting Firm |
72 | |
Item 3. Proposal for Advisory Approval of Executive Compensation |
73 | |
Item 4. Proposal to Adopt The Procter & Gamble 2019 Stock and Incentive Compensation Plan |
74 | |
78 | ||
Exhibits |
||
A-1 | ||
Exhibit B. The Procter & Gamble Company Audit Committee Policies |
B-1 | |
Exhibit C. The Procter & Gamble 2019 Stock and Incentive Compensation Plan |
C-1 |
PROXY SUMMARY | ||
Voting Matters and Board Recommendations
Voting Matter
|
Vote Standard
|
Board Vote Recommendation
|
See Page
| |||||
Item 1 |
Majority of votes cast |
FOR EACH NOMINEE |
6 | |||||
Item 2 |
Ratification of Independent Registered Public Accounting Firm |
Majority of votes cast |
FOR |
72 | ||||
Item 3 |
Majority of votes cast |
FOR |
73 | |||||
Item 4 |
Approval of The Procter & Gamble 2019 Stock and Incentive Compensation Plan |
Majority of votes cast |
FOR |
74 |
Our Board of Director Nominees
![]() |
|
2019 Proxy Statement i | ||||
PROXY SUMMARY | ||
Our Director Nominees
You are being asked to vote on the election of the 12 Directors listed below. Additional information about each nominees background and experience can be found beginning on page 10.
Name |
Position | Age | Board Tenure |
Committee Memberships | ||||
Francis S. Blake(I) |
Former Chairman of the Board and Chief Executive Officer of The Home Depot, Inc. |
70 | 4 years | Audit G&PR | ||||
Angela F. Braly(I) |
Former Chair of the Board, President and Chief Executive Officer of WellPoint, Inc. (now known as Anthem) |
58 | 9 years | Audit G&PR (Chair) | ||||
Amy L. Chang(I) |
Senior Vice President and General Manager of the Collaboration Technology Group at Cisco Systems, Inc.; Founder and Former Chief Executive Officer of Accompany, Inc. |
42 | 2 years | Audit I&T | ||||
Scott D. Cook(I) |
Chairman of the Executive Committee of the Board of Intuit Inc. |
67 | 19 years | None | ||||
Joseph Jimenez(I) |
Co-Founder and Managing Partner of Aditum Bio; Former Chief Executive Officer of Novartis AG |
59 | 1 year | C&LD I&T (Chair) | ||||
Terry J. Lundgren(I) |
Operating Partner of Long-Term Private Capital, a BlackRock fund; Former Executive Chairman, Chairman of the Board and CEO of Macys, Inc. |
67 | 6 years | C&LD (Chair) I&T | ||||
Christine M. McCarthy(I) |
Senior Executive Vice President and Chief Financial Officer of The Walt Disney Company |
64 | | § | ||||
W. James McNerney, Jr.(I) |
Senior Advisor at Clayton, Dubilier & Rice, LLC; Former Chairman of the Board, President and Chief Executive Officer of The Boeing Company |
70 | 16 years | C&LD G&PR | ||||
Nelson Peltz(I) |
Chief Executive Officer and Founding Partner of Trian Fund Management, L.P. |
77 | 1 year | G&PR I&T | ||||
David S. Taylor |
Chairman of the Board, President and Chief Executive Officer of the Company |
61 | 4 years | None | ||||
Margaret C. Whitman(I) |
Chief Executive Officer of Quibi; Former President and Chief Executive Officer of Hewlett Packard Enterprise |
63 | 8 years | I&T | ||||
Patricia A. Woertz(I) |
Former Chairman and Chief Executive Officer of Archer Daniels Midland Company |
66 | 11 years | Audit (Chair) G&PR |
(I) Independent
Mr. Cooks experience as the founder and former CEO of Intuit Inc., a successful consumer-facing global public technology company, and Mr. Peltzs experience as CEO and Founding Partner of Trian Fund Management, L.P., continue to be highly valuable to the Board and the Company. The Board therefore determined that these were special circumstances that warranted exceptions to the term and age limits, respectively, set forth in the Corporate Governance Guidelines and voted to nominate Mr. Cook and Mr. Peltz for re-election. In lieu of serving on any Board Committees, Mr. Cook devotes his time to additional strategic meetings with Company management.
Not on any Committees because the Committees are all comprised of independent Directors.
§The Board will determine Committee assignments for Ms. McCarthy upon her election.
C&LD | Compensation & Leadership Development |
G&PR | Governance & Public Responsibility |
I&T | Innovation & Technology |
ii The Procter & Gamble Company | ||
PROXY SUMMARY | ||
Corporate Governance Highlights
BOARD STRUCTURE & COMPOSITION
GOVERNANCE BEST PRACTICES
2019 Proxy Statement iii | ||||
PROXY SUMMARY | ||
SHAREHOLDER RIGHTS & ENGAGEMENT
iv The Procter & Gamble Company | ||
PROXY SUMMARY | ||
Corporate Citizenship
P&G aims to be a force for good and a force for growth. We know that the more we integrate and build Citizenship into how we do business, the bigger the impact we can have on the people we serve, the communities where we live and work, and the broader world that surrounds us. In turn, this helps us grow and build our business. Below are some highlights of our ongoing efforts to create long-term value for our consumers, customers, communities, and shareholders.
Ethics & Corporate Responsibility |
We believe in and have publicly committed to doing whats right and being a good corporate citizen.
We are governed by our Purpose, Values, and Principles. Our philosophy is that a reputation of trust and integrity is built over time, earned every day and is what sets us apart. P&G has a multi-functional Ethics & Compliance Office. Our employees hold themselves and one another accountable for operating with trust and integrity, stepping up as leaders and owners of the business. We publish key Company policies and practices at PG.com, including our Human Rights Policy Statement and our Core Tax Principles. | |
Community Impact |
Our brands touch the lives of nearly five billion people, and we are there when our products matter more than ever.
We provide clean drinking water through our Childrens Safe Drinking Water Program (delivering more than 15 billion liters since 2004). P&G partners with disaster relief agencies to provide product donations and services in response to disasters around the globe. Many P&G brands support individual programs like Tide Loads of Hopes mobile laundry units that help families impacted by disaster; more than 40 years of Dawn helping to save, protect and rehabilitate wildlife; and the Pampers 1 pack = 1 life-saving vaccine program in partnership with UNICEF. | |
Diversity & Inclusion |
Our diversity helps us connect with the consumers we serve around the world, and we believe that while diversity is essential in all we do, inclusion changes the game.
We are using our voice to spark dialogue, call attention to bias, and motivate change through ads like The Talk, Love Over Bias, and We Believe. P&G is a Steering Committee Member of CEO Action for Diversity & Inclusion, the largest CEO-driven business commitment to advance diversity and inclusion in the workplace. P&G has been recognized among Forbes Best Employers for Diversity (U.S.), with more than 140 nationalities represented in our global workforce. | |
Gender |
We aspire to build a better world for all of us inside and outside P&G a world free from bias and with equal voice and equal representation for all individuals.
We partner with prominent advocates for gender equality to host #WeSeeEqual forums at P&G sites globally. P&G leaders connect with local female entrepreneurs around the world, in partnership with WEConnect International, to help empower and educate women as they grow their businesses. We promote brand campaigns that champion gender equality, challenge gender stereotypes, and encourage women to be fearless in pursuit of their goals. | |
Environmental |
Building on our legacy of environmental leadership, we set and achieve ambitious goals that seek to address some of the worlds most pressing environmental challenges.
Constantly strive to outperform our targets, launching Ambition 2030 goals in 2018 to drive responsible consumption through our brands supply chain, society, and our employees. Founding member of the Alliance to End Plastic Waste, a cross value chain partnership committed to advancing solutions to eliminate plastic waste in the environment. Invest in brand innovation that helps the Company and our consumers reduce their environmental impact. |
You can find more details about our work in each of these Citizenship pillars in our 2018 Citizenship Report, available at https://www.pg.com/citizenship2018.
2019 Proxy Statement v | ||||
PROXY SUMMARY | ||
Key Elements of FY 2018-19 Executive Compensation Program
CEO Compensation Highlights
Compensation Program Improvements for FY 2018-19
vi The Procter & Gamble Company | ||
GLOSSARY OF TERMS | ||
Commonly Used Terms in This Proxy Statement
C&LD |
Compensation & Leadership Development | |
CEO |
Chief Executive Officer | |
CFO |
Chief Financial Officer | |
CHRO |
Chief Human Resources Officer | |
CLO |
Chief Legal Officer | |
EDCP |
Executive Deferred Compensation Plan | |
EGLIP |
Executive Group Life Insurance Program | |
EPS |
Earnings Per Share | |
FY |
Fiscal Year | |
G&PR |
Governance & Public Responsibility | |
GBU |
Global Business Unit | |
I&T |
Innovation & Technology | |
IRA |
International Retirement Arrangement | |
IRP |
International Retirement Plan | |
LTIP |
Long-Term Incentive Program | |
NEO |
Named Executive Officer | |
NYSE |
New York Stock Exchange | |
PSP |
Performance Stock Program | |
PST |
Profit Sharing Trust and Employee Stock Ownership Plan | |
PSU |
Performance Stock Unit | |
RSU |
Restricted Stock Unit | |
SEC |
Securities and Exchange Commission | |
SMO |
Selling and Market Operations | |
STAR |
Short-Term Achievement Reward | |
TSR |
Total Shareholder Return |
2019 Proxy Statement 1 | ||||
VOTING AND MEETING INFORMATION | ||
Voting and Meeting Information
In connection with the Companys 2019 annual meeting of shareholders, which will take place on October 8, 2019, the Board of Directors has provided these materials to you, either over the Internet or via mail. The Notice was mailed to Company shareholders beginning August 23, 2019, and our proxy materials were posted on the website referenced in the Notice on that same date. The Company, on behalf of its Board, is soliciting your proxy to vote your shares at the 2019 annual meeting of shareholders. We solicit proxies to give shareholders of record an opportunity to vote on matters that will be presented at the annual meeting. In the proxy statement, you will find information on these matters, which is provided to assist you in voting your shares.
2 The Procter & Gamble Company | ||
VOTING AND MEETING INFORMATION | ||
2019 Proxy Statement 3 | ||||
VOTING AND MEETING INFORMATION | ||
4 The Procter & Gamble Company | ||
VOTING AND MEETING INFORMATION | ||
2019 Proxy Statement 5 | ||||
ELECTION OF DIRECTORS | ||
|
|
|
![]() |
2019 Proxy Statement 7 | ||||
ELECTION OF DIRECTORS | ||
Our Director Nominees Combined Skills and Experience | ||
Consumer Industry/Retail |
Directors with experience in dealing with consumers, particularly in the areas of marketing and selling products or services to consumers, provide valuable insights to the Company. They understand consumer needs, recognize products and marketing campaigns that might resonate with consumers, and identify potential changes in consumer trends and buying habits. | |
Corporate Governance |
Directors with experience in corporate governance, such as service on boards and board committees, or as governance executives of other large, public companies, are familiar with the dynamics and operation of a board of directors and the impact that governance policies have on the Company. This experience supports the Companys goals of strong Board and management accountability, transparency, and protection of shareholder interests. | |
Digital, Technology, and Innovation |
Directors with digital and technology experience help the Company understand the evolution of fast-paced technology, assess and respond to potential information security challenges, and improve efficiency and productivity through oversight of the selection and implementation of new technologies to enhance business operations, marketing, and selling. Additionally, innovation is one of the Companys core strengths and is critical in helping us translate our consumer understanding into new and successful products. Directors with an understanding of innovation help the Company focus its efforts in this important area and track progress against strategic goals and benchmarks. | |
Finance |
Directors with an understanding of accounting and financial reporting processes, particularly in large, global businesses, provide an important oversight role. The Company employs several financial targets to measure its performance, and accurate financial reporting is critical to the Companys legal compliance and overall success. Directors with financial experience are essential for ensuring effective oversight of the Companys financial measures and processes. | |
Government/Regulatory |
Directors with government experience, whether as members of the government or through extensive interactions with government and government agencies, can recognize, identify, and understand the key issues the Company faces in an economy increasingly affected by the role of governments around the world. This experience is particularly helpful during current times of increased volatility and uncertainty in global politics and economics. | |
International |
Directors who work in global companies have experience in markets outside of the United States and bring valuable knowledge to the Company, including exposure to different cultural perspectives and practices, and provide critical insight in light of the Companys global scope and significant international revenues. |
8 The Procter & Gamble Company | ||
ELECTION OF DIRECTORS | ||
Leadership, Strategy, and Risk Management |
Directors with significant leadership experience over an extended period, including as chief executive officers, provide the Company with special insights. These individuals demonstrate a practical understanding of how large organizations operate, the importance of talent management, and the method of setting employee and executive compensation. They understand strategy, productivity, and risk management, and how these factors impact the Companys operations and controls. Further, they possess recognized leadership qualities and can identify and develop leadership qualities in others. | |
Marketing |
Directors with experience identifying, developing, and marketing new products, as well as identifying new areas for existing products, can positively impact the Companys operational results, including by helping the Company understand and anticipate evolving marketing practices. |
2019 Proxy Statement 9 | ||||
ELECTION OF DIRECTORS | ||
The Board of Directors recommends a vote FOR each of the following Director nominees to hold office until the 2020 annual meeting of shareholders and until their successors are elected.
10 The Procter & Gamble Company | ||
ELECTION OF DIRECTORS | ||
2019 Proxy Statement 11 | ||||
ELECTION OF DIRECTORS | ||
12 The Procter & Gamble Company | ||
ELECTION OF DIRECTORS | ||
2019 Proxy Statement 13 | ||||
ELECTION OF DIRECTORS | ||
14 The Procter & Gamble Company | ||
ELECTION OF DIRECTORS | ||
2019 Proxy Statement 15 | ||||
CORPORATE GOVERNANCE | ||
The Companys Purpose, Values, and Principles (our PVPs) are the foundation of everything we do, including Corporate Governance. This foundation of integrity is critical to delivering long-term value for our consumers, customers, and shareholders. As a result, we take seriously the governance practices and policies that help protect the well-being of P&G and its shareholders.
ISG Principles |
P&G Practice | |
Principle 1 |
||
Boards are accountable to shareholders. |
Annual Board self-assessments Declassified Board all Directors elected annually Proxy access for Director nominees Individual Directors tender resignation if they fail to receive majority of votes cast No poison pill Extensive disclosure of corporate governance and Board practices | |
Principle 2 |
||
Shareholders should be entitled to voting rights in proportion to their economic interest. |
One share, one vote No disparate voting rights | |
Principle 3 |
||
Boards should be responsive to shareholders and be proactive in order to understand their perspectives. |
Directors available for shareholder engagement Shareholder outreach process Disclose key actions taken in response to shareholder feedback | |
Principle 4 |
||
Boards should have a strong, independent leadership structure. |
Annual review and determination of leadership structure Independent Lead Director if Chairman not independent Lead Director has robust role and significant duties | |
Principle 5 |
||
Boards should adopt structures and practices that enhance their effectiveness. |
11 of 12 Director nominees are Independent All 4 Committees fully independent 95% average attendance by incumbent Directors at Board and Committee meetings in FY 2018-19 Specified retirement age and term limits for Directors | |
Principle 6 |
||
Boards should develop management incentive structures that are aligned with the long-term strategy of the company. |
Board oversees executive compensation programs to align with long-term strategy of the Company Combination of short- and long-term performance goals Executive share ownership program and equity holding requirements |
16 The Procter & Gamble Company | ||
CORPORATE GOVERNANCE | ||
2019 Proxy Statement 17 | ||||
CORPORATE GOVERNANCE | ||
18 The Procter & Gamble Company | ||
CORPORATE GOVERNANCE | ||
2019 Proxy Statement 19 | ||||
CORPORATE GOVERNANCE | ||
Name |
Board | Audit | Compensation & Leadership |
Governance Responsibility |
Innovation & Technology | |||||
Francis S. Blake |
● |
● |
● |
|||||||
Angela F. Braly |
● |
● |
Chair |
|||||||
Amy L. Chang |
● |
● |
● | |||||||
Scott D. Cook |
● |
|||||||||
Joseph Jimenez |
● |
● |
Chair | |||||||
Terry J. Lundgren |
● |
Chair |
● | |||||||
W. James McNerney, Jr. |
Lead |
● |
● |
|||||||
Nelson Peltz |
● |
● |
● | |||||||
David S. Taylor |
Chair |
|||||||||
Margaret C. Whitman |
● |
● | ||||||||
Patricia A. Woertz |
● |
Chair |
● |
|||||||
Total FY 2018-19 Meetings |
7 |
8 |
6 |
6 |
2 |
In lieu of serving on any Board Committees, Mr. Cook devotes his time to additional strategic meetings with Company management.
20 The Procter & Gamble Company | ||
CORPORATE GOVERNANCE | ||
2019 Proxy Statement 21 | ||||
CORPORATE GOVERNANCE | ||
22 The Procter & Gamble Company | ||
CORPORATE GOVERNANCE | ||
Audit Committee Oversees the Companys overall risk management process, focusing on accounting and financial controls, financial statement integrity, information security, cybersecurity, legal and regulatory compliance, tax policy and compliance, business continuity planning, and ethics and compliance programs, and routinely discusses the Companys risk profile, risk management, and exposure with management, internal auditors, and our independent registered public accounting firm.
Compensation & Leadership Development Committee Reviews risks related to the development and succession planning of the Companys executive officers as well as risks associated with the Companys compensation policies and practices, as discussed further below under Compensation-Related Risk.
Governance & Public Responsibility Committee Reviews risks related to the Companys corporate governance structure and processes, including Director qualifications, succession planning, and independence, as well as risks related to product quality, public policy, social issues, environmental sustainability, and the Companys reputation.
Innovation & Technology Committee Reviews risks related to emerging technologies, the changing media landscape, the Companys integration of new technology, ingredient safety, and our overall innovation strategy.
|
2019 Proxy Statement 23 | ||||
CORPORATE GOVERNANCE | ||
24 The Procter & Gamble Company | ||
CORPORATE GOVERNANCE | ||
2019 Proxy Statement 25 | ||||
CORPORATE GOVERNANCE | ||
26 The Procter & Gamble Company | ||
CORPORATE GOVERNANCE | ||
2019 Proxy Statement 27 | ||||
DIRECTOR COMPENSATION | ||
28 The Procter & Gamble Company | ||
DIRECTOR COMPENSATION | ||
The following table and footnotes provide information regarding the compensation paid to the Companys non-employee Directors in FY 2018-19. Directors who are employees of the Company receive no compensation for their service as Directors.
DIRECTOR COMPENSATION |
||||||||||||
Fees |
||||||||||||
Name |
Annual |
Committee |
Total Fees ($) |
Stock |
All
Other |
Total | ||||||
Francis S. Blake |
110,000 |
|
110,000 |
175,000 |
0 |
285,000 | ||||||
Angela F. Braly |
110,000 | 15,000 | 125,000 | 175,000 | 0 | 300,000 | ||||||
Amy Chang |
110,000 | | 110,000 | 175,000 | 0 | 285,000 | ||||||
Kenneth I. Chenault |
68,444 | | 68,444 | 175,000 | 0 | 243,444 | ||||||
Scott D. Cook |
110,000 | 15,000 | 125,000 | 175,000 | 0 | 300,000 | ||||||
Joseph Jimenez |
110,000 | | 110,000 | 175,000 | 0 | 285,000 | ||||||
Terry J. Lundgren |
110,000 | 20,000 | 130,000 | 175,000 | 0 | 305,000 | ||||||
W. James McNerney, Jr. |
110,000 | 30,000 | 140,000 | 175,000 | 0 | 315,000 | ||||||
Nelson Peltz |
110,000 | | 110,000 | 175,000 | 0 | 285,000 | ||||||
Margaret C. Whitman |
110,000 | | 110,000 | 175,000 | 0 | 285,000 | ||||||
Patricia A. Woertz |
110,000 | 25,000 | 135,000 | 175,000 | 0 | 310,000 | ||||||
Ernesto Zedillo |
68,444 | 68,444 | 175,000 | 0 | 243,444 |
1 Director fees are paid quarterly. Each Director may elect to take these fees in cash, unrestricted stock, RSUs (which vest immediately), or a combination of the three. The RSUs earn dividend equivalents that are subject to the same vesting provision as the underlying RSUs and are accrued in the form of additional RSUs each quarter and credited to each Directors holdings. Mr. Blake elected to take $105,000 of his fees in unrestricted stock, which had a grant date fair value of $105,146. Ms. Braly elected to take $120,000 of her fees in RSUs, which had a grant date fair value of $120,196. Mr. Chenault retired from the Board on February 13, 2019, and his retainer was prorated accordingly. He elected to take $13,444 of his fees in cash and $55,000 in RSUs, which had a grant date fair value of $55,071. Mr. Cook elected to take $120,000 of his fees in unrestricted stock, which had a grant date fair value of $120,196. Mr. Jimenez elected to take $105,000 of his fees in RSUs, which had a grant date fair value of $105,146. Mr. Lundgren elected to take $125,000 of his fees in RSUs, which had a grant date fair value of $125,254. Mr. McNerney elected to take $135,000 of his fees in unrestricted stock, which had a grant date fair value of $135,063. The remaining Directors took their fees in cash. Dr. Zedillo retired from the Board on February 13, 2019, and his retainer was prorated accordingly.
2 Each year, upon election at the Companys annual meeting of shareholders, every Director is awarded a $175,000 grant of RSUs. These RSUs vest after one year as long as the Director remains on the Board. Each Director has 2,176 RSUs outstanding (representing the grant on October 9, 2018, and subsequent dividend equivalents).
In addition, Ms. Braly has 4,992 shares of retirement restricted stock outstanding as of June 30, 2019.
3 For all Board meetings throughout the fiscal year, Directors were entitled to bring a guest so long as the Director used the Company aircraft to attend the meeting and the guests attendance did not result in any incremental aircraft cost. Directors are also covered under the same insurance policy as all Company employees for accidental death while traveling on Company business (coverage is $750,000 for each Director). The incremental cost to the Company for this benefit is $3,541. In addition, the Company maintains a Charitable Awards Program for current and retired Directors who were participants prior to July 1, 2003. Under this program, at their death, the Company donates $1,000,000 per Director to up to five qualifying charitable organizations selected by each Director. Directors derive no financial benefit from the program because the charitable deductions accrue solely to the Company. The Company funds this contribution from general corporate assets. In FY 2018-19, no payments were made. The Company also made a $500 donation on behalf of each Director to the Childrens Safe Drinking Water Program or to a different charity of their choice. These donations were also funded from general corporate assets, and the Directors derive no financial benefit from these donations because the charitable deductions accrue solely to the Company. In recognition of Kenneth I. Chenaults service on the Board, at his retirement the Company made a contribution of $10,000 to the Smithsonians National Museum of African American History and Culture. As an employee Director, Mr. Taylor did not receive a retainer, fees, or a stock award.
2019 Proxy Statement 29 | ||||
C&LD COMMITTEE REPORT | ||
Compensation Committee Report
The Compensation & Leadership Development Committee of the Board of Directors has reviewed and discussed the following section of this proxy statement entitled Compensation Discussion & Analysis with management. Based on this review and discussion, the Committee has recommended to the Board that the section entitled Compensation Discussion & Analysis, as it appears on the following pages, be included in this proxy statement and incorporated by reference into the Companys Annual Report on Form 10-K for the fiscal year ended June 30, 2019.
Terry J. Lundgren, Chair
Joseph Jimenez
W. James McNerney, Jr.
30 The Procter & Gamble Company | ||
COMPENSATION DISCUSSION & ANALYSIS | ||
Compensation Discussion & Analysis
Introduction
The focus of this discussion and analysis is on the Companys compensation philosophies and programs for its named executive officers (NEOs) for FY 2018-19. Effective July 1, 2019, the Board appointed Mr. Moeller as Chief Operating Officer, in addition to his then-current responsibilities. Also effective July 1, 2019, as part of the organizational redesign, Ms. Ferguson-McHugh was appointed CEO-Family Care and P&G Ventures, and Ms. Tastad was appointed Group President-North America and Chief Sales Officer.
|
David S. Taylor Chairman of the Board, President and Chief Executive Officer
| |||||
|
Jon R. Moeller Vice Chairman, Chief |
![]() |
Mary Lynn Ferguson-McHugh CEO-Family Care and P&G Ventures | |||
|
Deborah P. Majoras Chief Legal Officer and Secretary |
![]() |
Carolyn M. Tastad Group President-North |
2019 Proxy Statement 31 | ||||
COMPENSATION DISCUSSION & ANALYSIS | ||
FY 2018-19 ResultsKey Compensation Measures
The Companys focus for FY 2018-19 was on the execution of four key strategic priorities: extend our margin of competitive superiority across the five consumer touchpoints (product, package, brand communication, retail execution, and value), drive productivity savings to fund investments for growth and enhance our industry leading margins, strengthen our organization structure, and constructively disrupt our industry. The Company met or exceeded its going-in targets for its key compensation measures. This led to above-target payouts in our bonus programs.
Key Compensation Measures |
Original FY 2018-19 Targets1 |
FY 2018-19 Actuals2 | ||
Organic Sales Growth3 |
2% to 3% | 5% | ||
Core EPS Growth4 |
3% to 8% | 7% | ||
Adjusted Free Cash Flow Productivity5 |
³90% | 105% |
1 The targets above reflect the original FY 2018-19 financial guidance provided by the Company on July 31, 2018.
2 FY 2018-19 actuals for Organic Sales Growth, Core EPS Growth and Adjusted Free Cash Flow Productivity were used in the calculation of Year 3 Performance Stock Program results, as further detailed on page 42.
3 Organic Sales Growth is a measure of sales growth excluding the impacts of acquisitions, divestitures, foreign exchange and the impact from the July 1, 2018 adoption of a new accounting standard for Revenue from Contracts with Customers from year-over-year comparisons. See Exhibit A for a reconciliation of non-GAAP measures.
4 Core EPS Growth is a measure of the Companys diluted net earnings per share growth, adjusted for the gain on dissolution of the PGT Healthcare partnership, the Shave Care impairment charge and anti-dilutive impacts in fiscal 2019, the transitional impacts of the U.S. Tax Act and losses on early extinguishment of debt in fiscal 2018 and incremental restructuring charges in both fiscal 2019 and 2018. See Exhibit A for a reconciliation of non-GAAP measures including details on the items being adjusted.
5Adjusted Free Cash Flow Productivity is the ratio of adjusted free cash flow (Operating Cash Flow less Capital Expenditures and the tax payment for the transitional tax related to the U.S. Tax Act) to Net Earnings adjusted for the gain on dissolution of the PGT Healthcare partnership and the Shave Care impairment charge. See Exhibit A for a reconciliation of non-GAAP measures.
32 The Procter & Gamble Company | ||
COMPENSATION DISCUSSION & ANALYSIS | ||
Executive Compensation Practices
Our executive compensation practices are designed to incent strong performance, support good governance, and mitigate excessive risk-taking.
2019 Proxy Statement 33 | ||||
COMPENSATION DISCUSSION & ANALYSIS | ||
![]() |
![]() |
![]() |
34 The Procter & Gamble Company | ||
COMPENSATION DISCUSSION & ANALYSIS | ||
Each year, the C&LD Committee evaluates and, if appropriate, updates the composition of the Peer Group. Changes to the Peer Group are carefully considered and made infrequently to ensure continuity from year to year. For FY 2018-19, the Committee did not make any changes to the Peer Group, which consists of the following companies:
3M | Colgate-Palmolive | Home Depot | Merck | Pfizer | ||||
AT&T | ExxonMobil | IBM | Microsoft | United Technologies | ||||
Boeing | Ford Motor Co. | Johnson & Johnson | Mondelez | Verizon Communications | ||||
Chevron | General Electric | Kimberly-Clark | Nike | Wal-Mart Stores | ||||
Coca-Cola | HP Inc. | Lockheed Martin | PepsiCo |
2019 Proxy Statement 35 | ||||
COMPENSATION DISCUSSION & ANALYSIS | ||
STAR awards are now calculated using the following formula:
36 The Procter & Gamble Company | ||
COMPENSATION DISCUSSION & ANALYSIS | ||
2019 Proxy Statement 37 | ||||
COMPENSATION DISCUSSION & ANALYSIS | ||
The C&LD Committee then reviewed the recommendations provided for the 18 Business Unit Performance Factors and, after considering the performance of the total Company and the appropriate combination of Business Unit Performance Factors for each NEO, approved the following STAR awards:
FY 2018-19 STAR AWARDS | ||||||||||||||
NEO |
STAR Target ($)
|
Business Unit (70% Weight)
|
Total Company (30% Weight)
|
STAR ($)
|
STAR Award (% of Target)
| |||||||||
David Taylor |
3,400,000 | 154 | 171 | 5,409,400 | 159 | |||||||||
Jon R. Moeller |
1,365,000 | 154 | 171 | 2,171,715 | 159 | |||||||||
Mary Lynn Ferguson-McHugh |
880,000 | 177 | 171 | 1,543,300 | 175 | |||||||||
Deborah P. Majoras |
979,000 | 154 | 171 | 1,557,589 | 159 | |||||||||
Carolyn M. Tastad |
760,000 | 190 | 171 | 1,400,680 | 184 |
38 The Procter & Gamble Company | ||
COMPENSATION DISCUSSION & ANALYSIS | ||
To determine the vested PSUs, at the end of each three-year performance period, the C&LD Committee multiplies the initial PSU grant (plus compounded dividend equivalents) by the weighted average of the Performance Factors and the new Relative TSR modifier, which is set at 125% for results in the top quartile of our peer set, and 75% for results in the bottom quartile. The formula is as follows:
2019 Proxy Statement 39 | ||||
COMPENSATION DISCUSSION & ANALYSIS | ||
FY 2018-19 LONG-TERM INCENTIVE GRANTS
The following long-term incentive grants were made in FY 2018-19. The actual compensation realized by each NEO will be determined by future Company performance.
FY 2018-19 LONG-TERM INCENTIVE GRANTS | ||||||||||||
PSP Grant | LTIP Grant | Total | ||||||||||
PSUs | Grant Date Fair Value |
Options | RSUs | Grant Date Fair Value |
Grant Date Fair Value | |||||||
NEO |
(#) | ($) | (#) | (#) | ($) | ($) | ||||||
David Taylor |
55,716 | 6,375,025 | 230,586 | 31,698 | 6,375,101 | 12,750,126 | ||||||
Jon R. Moeller |
26,315 | 3,010,962 | 160,153 | 7,638 | 3,010,882 | 6,021,844 | ||||||
Mary Lynn Ferguson-McHugh |
13,475 | 1,541,810 | 54,672 | 7,823 | 1,541,832 | 3,083,642 | ||||||
Deborah P. Majoras |
12,237 | 1,400,158 | 49,650 | 7,104 | 1,400,164 | 2,800,322 | ||||||
Carolyn M. Tastad |
13,227 | 1,513,433 | 26,833 | 11,518 | 1,513,444 | 3,026,877 |
40 The Procter & Gamble Company | ||
COMPENSATION DISCUSSION & ANALYSIS | ||
PSP GOAL SETTING
In conjunction with deciding the amount and allocation of the NEOs long-term incentive opportunities for FY 2018-19, the C&LD Committee set the PSP Performance Factors listed below for the three-year performance period starting July 1, 2018 through June 30, 2021. Additionally, based on shareholder feedback, the C&LD Committee established a relative TSR multiplier at 75% for three-year TSR results in the bottom quartile of the consumer products competitive peer set, and 125% for results in the top quartile. The delivery of results against these factors will determine the ultimate payout for this portion of compensation.
PSP GOALS FOR PERFORMANCE PERIOD JULY 1, 2018JUNE 30, 2021 | ||||||||||||||||||
Organic Sales Growth (30% Weighting)1 |
Constant Currency Core (20% Weighting)2 |
Core EPS Growth (30% Weighting)3 |
Adjusted
Free (20% Weighting)4 |
|||||||||||||||
% Growth |
Payout Factor |
% Growth |
Payout Factor |
% Growth |
Payout Factor |
% | Payout Factor |
|||||||||||
80th | 200% | ³10.7 | 200% | ³11.3 | 200% | ³115 | 200% | |||||||||||
70th | 167% | 9.0 | 167% | 9.6 | 167% | 107 | 167% | |||||||||||
60th | 133% | 7.4 | 133% | 8.0 | 133% | 98 | 133% | |||||||||||
Target 50th | 100% | Target 5.7 | 100% | Target 6.3 | 100% | Target 90 | 100% | |||||||||||
40th | 67% | 4.0 | 67% | 4.6 | 67% | 82 | 67% | |||||||||||
30th | 33% | 2.4 | 33% | 3.0 | 33% | 73 | 33% | |||||||||||
£20th | 0% | £0.7 | 0% | £1.3 | 0% | £65 | 0% |
1 Organic Sales Growth is a measure of sales growth excluding the impacts of acquisitions, divestitures, foreign exchange and (as appropriate) certain other items from year-over-year comparisons, and will be based on the 3-year compound annual growth rate within a peer group of directly competitive consumer product companies. See Exhibit A for a reconciliation of non-GAAP measures.
2 Constant Currency Core Before-Tax Operating Profit Growth is a measure of operating profit growth adjusted to exclude foreign exchange impacts and certain items that are not deemed to be part of the Companys sustainable results, and will be based on the 3-year compound annual growth rate. See Exhibit A for a reconciliation of non-GAAP measures.
3 Core EPS Growth is a measure of the Companys diluted net earnings per share growth, adjusted for certain items that are not deemed to be part of the Companys sustainable results, and will be based on the 3-year compound annual growth rate. See Exhibit A for a reconciliation of non-GAAP measures.
4 Adjusted Free Cash Flow Productivity is the ratio of the 3-year sum of Operating Cash Flow excluding (as appropriate) certain impacts less the 3-year sum of Capital Expenditures to the 3-year sum of Net Earnings excluding (as appropriate) certain charges. See Exhibit A for a reconciliation of non-GAAP measures.
2019 Proxy Statement 41 | ||||
COMPENSATION DISCUSSION & ANALYSIS | ||
LOOKING BACK: REALIZED PAY FOR PSP PERFORMANCE PERIOD JULY 1, 2016JUNE 30, 2019
In addition to setting the performance goals for the new PSP cycle, the C&LD Committee reviewed the results for the Performance Period (July 1, 2016 to June 30, 2019), which pays out at the end of FY 2018-19. The C&LD Committee reviewed these results against the goals established at the beginning of that Performance Period to determine the realized pay for each NEO. Note that the measures used in the FY 2016-19 program differ from those used in programs beginning with performance period July 1, 2018 to June 30, 2021 as follows: Organic Sales Growth is not a relative measure based on a percentile rank within a peer group, and the R-TSR modifier is not included.
PSP RESULTS FOR JULY 1, 2016JUNE 30, 2019 | ||||||||
Performance Factors
|
Target
|
Actual
|
Weight
|
Result
| ||||
Organic Sales Growth1
|
2.8%
|
2.8%
|
30%
|
100%
| ||||
Constant Currency Core Before-Tax Operating Profit Growth2
|
4.7%
|
5.0%
|
20%
|
110%
| ||||
Core EPS Growth3
|
6.0%
|
7.2%
|
30%
|
140%
| ||||
Adjusted Free Cash Flow Productivity4
|
90%
|
101%
|
20%
|
144%
| ||||
PSP Payout (Average of Performance Factors)
|
123%
|
1 Organic Sales Growth is a measure of sales growth excluding the impacts of the India Goods and Services Tax implementation in fiscal 2018, the adoption of a new accounting standard on revenue recognition in fiscal 2019, acquisitions, divestitures, and foreign exchange from year-over-year comparisons.
2 Constant Currency Core Before-Tax Operating Profit Growth is the 3-year compound annual growth rate of Before-Tax Operating Profit, adjusted to exclude foreign exchange impacts, charges for certain European legal matters in fiscal 2016, the charges for Shave Care impairment in fiscal 2019 and incremental restructuring in all periods. See Exhibit A for a reconciliation of non-GAAP measures.
3 Core EPS Growth is the 3-year compound annual growth rate of the Companys diluted net earnings per share from continuing operations, adjusted for charges for early extinguishment of debt in fiscal 2017 and 2018, the transitional impacts of the U.S. Tax Act in fiscal 2018, the gain on dissolution of the PGT Healthcare partnership, the charges for Shave Care impairment and anti-dilutive impacts in fiscal 2019 and incremental restructuring in all periods. See Exhibit A for a reconciliation of non-GAAP measures.
4 Adjusted Free Cash Flow Productivity is the ratio of the 3-year sum of Operating Cash Flow excluding certain divestiture impacts in fiscal 2017 and tax payments related to the transitional taxes from the U.S. Tax Act in fiscal 2019 less the 3-year sum of Capital Expenditures to the 3-year sum of the Net Earnings excluding the Shave Care impairment charges and the gain on the dissolution of the PGT Healthcare partnership in fiscal 2019, the transitional impact of the U.S. Tax Act in fiscal 2018, the losses on early extinguishment of debt in fiscal 2018 and 2017 and the gain on the sale of the Beauty Brands business in fiscal 2017. See Exhibit A for a reconciliation of non-GAAP measures.
Based on results delivered, the NEOs received PSP payouts at 123% of target, which resulted in the following PSU awards for each NEO.
REALIZED PAY FOR PERFORMANCE PERIOD JULY 1, 2016JUNE 30, 2019 | ||||||||||
Named Executive Officer
|
Initial # of
|
Market
Value
|
PSP Payout
|
Final # of
|
Market Value of
| |||||
David Taylor
|
70,804
|
7,763,614
|
123%
|
87,089
|
9,549,309
| |||||
Jon R. Moeller
|
31,934
|
3,501,545
|
123%
|
39,279
|
4,306,942
| |||||
Mary Lynn Ferguson-McHugh
|
17,819
|
1,953,866
|
123%
|
21,918
|
2,403,309
| |||||
Deborah P. Majoras
|
16,964
|
1,860,067
|
123%
|
20,866
|
2,287,957
| |||||
Carolyn M. Tastad
|
16,226
|
1,779,181
|
123%
|
19,958
|
2,188,395
|
1 The value of PSUs at target and awarded was calculated by multiplying the number of PSUs and accumulated dividend equivalents by the Company stock price as of June 28, 2019. These PSUs will deliver in shares of Common Stock or RSUs (as elected by the participants) in August 2019. The market value of the final award does not include a final payment of dividend equivalents on the PSUs, which will take place on August 15, 2019, prior to delivery in shares.
42 The Procter & Gamble Company | ||
COMPENSATION DISCUSSION & ANALYSIS | ||
2019 Proxy Statement 43 | ||||
COMPENSATION DISCUSSION & ANALYSIS | ||
44 The Procter & Gamble Company | ||
COMPENSATION DISCUSSION & ANALYSIS | ||
2019 Proxy Statement 45 | ||||
COMPENSATION DISCUSSION & ANALYSIS | ||
46 The Procter & Gamble Company | ||
EXECUTIVE COMPENSATION | ||
The following tables, footnotes, and narratives provide information regarding the compensation, benefits, and equity holdings in the Company for the NEOs.
The following table and footnotes provide information regarding the compensation of the NEOs, for the fiscal years shown.
FY 201819 SUMMARY COMPENSATION TABLE | ||||||||||||||||||
Name and Principal Position
|
Year
|
Salary
|
Bonus1
|
Stock
|
Option
|
Non- Incentive Plan Compen- sation ($)
|
Change in qualified
|
All
|
Total ($)
| |||||||||
David Taylor |
||||||||||||||||||
Chairman of the |
201819 | 1,650,000 | 5,409,400 | 9,768,118 | 3,251,263 | 0 | 0 | 420,031 | 20,498,812 | |||||||||
Board, President |
201718 | 1,600,000 | 2,736,000 | 9,642,358 | 3,125,011 | 0 | 0 | 250,887 | 17,354,256 | |||||||||
and Chief Executive |
201617 | 1,600,000 | 4,080,384 | 9,226,929 | 3,000,001 | 0 | 0 | 188,863 | 18,096,177 | |||||||||
Jon R. Moeller |
201819 | 1,050,000 | 2,171,715 | 3,911,517 | 2,258,157 | 0 | 0 | 85,939 | 9,477,328 | |||||||||
Vice Chairman and |
201718 | 1,000,000 | 1,111,500 | 3,637,453 | 2,100,126 | 0 | 0 | 110,277 | 7,959,356 | |||||||||
Chief Financial Officer |
201617 | 950,000 | 1,453,637 | 3,520,417 | 2,029,563 | 0 | 0 | 75,184 | 8,028,801 | |||||||||
Mary Lynn |
||||||||||||||||||
Ferguson-McHugh |
||||||||||||||||||
Group President |
201819 | 877,500 | 1,543,300 | 2,429,675 | 770,875 | 0 | 0 | 75,741 | 5,697,091 | |||||||||
Global Family Care |
201718 201617 |
847,500 817,500 |
698,062 1,409,974 |
2,550,837 2,370,115 |
813,390 755,001 |
0 0 |
0 0 |
67,867 80,329 |
4,977,656 5,432,919 | |||||||||
Deborah P. Majoras |
||||||||||||||||||
Chief Legal Officer and Secretary |
201819 | 872,500 | 1,557,589 | 2,207,352 | 700,065 | 0 | 0 | 90,516 | 5,428,022 | |||||||||
Carolyn M. Tastad |
||||||||||||||||||
Group President |
201819 | 736,667 | 1,400,680 | 2,734,909 | 378,345 | 0 | 657,000 | 80,954 | 5,988,555 | |||||||||
North America Selling and Market Operations |
1 For FY 2018-19, Bonus reflects FY 2018-19 STAR awards that will be paid on September 13, 2019. Each NEO who participated in STAR could elect to take his or her STAR award in cash, deferred compensation, or stock options. For FY 2018-19, Mr. Taylor chose to take his STAR award as 25% stock options, 70% cash, and 5% deferred compensation. Ms. Tastad chose to take her award as stock options. Ms. Ferguson-McHugh, Ms. Majoras, and Mr. Moeller took their awards in cash.
2 For FY 2018-19, Stock Awards include the grant date fair value of any PST Restoration Program and Supplemental Retirement Income Program awards and the PSUs granted in February 2019 under the PSP. It also includes the grant date fair value of RSUs granted in February 2019 under the LTIP Stock Grant. The amount shown is determined in accordance with FASB ASC Topic 718. For more information regarding these awards, including retention and vesting requirements and applicable performance measures, see pages 37-42 of the Compensation Discussion & Analysis.
3 Option Awards for FY 2018-19 include the grant date fair value of each LTIP Stock Grant, determined in accordance with FASB ASC Topic 718.
2019 Proxy Statement 47 | ||||
EXECUTIVE COMPENSATION | ||
We utilize an industry standard lattice-based valuation model to calculate the fair value for stock options granted. Assumptions utilized in the model, which are evaluated and revised to reflect market conditions and experience, were as follows:
Years ended June 30: |
2019 |
2018 |
2017 | |||
Interest rate |
2.52.7% |
1.92.9% |
0.82.6% | |||
Weighted average interest rate |
2.6% |
2.8% |
2.6% | |||
Dividend yield |
3.0% |
3.1% |
3.2% | |||
Expected volatility |
17% |
18% |
15% | |||
Expected life in years |
9.2 |
9.2 |
9.6 |
Lattice-based option valuation models incorporate ranges of assumptions for inputs and those ranges are disclosed in the preceding table. Expected volatility is based on a combination of historical volatility of our stock and implied volatilities of call options on our stock. We use historical data to estimate option exercise and employee termination patterns within the valuation model. The expected life of options granted is derived from the output of the option valuation model and represents the average period of time that options granted are expected to be outstanding. The interest rate for periods within the contractual life of the options is based on the U.S. Treasury yield curve in effect at the time of grant. For information on the valuation assumptions with respect to grants made in prior fiscal years, please see the corresponding note to the Consolidated Financial Statements contained in the Companys Annual Report for the respective fiscal year. For more information regarding these awards, including retention and vesting requirements and applicable performance measures, see page 39 of the Compensation Discussion & Analysis.
4 This column reflects aggregate changes in the actuarial present value of Ms. Tastads pension benefits under The Procter & Gamble Company Global IRA and The Procter & Gamble Company Canada Plan. None of the other NEOs has a pension plan. None of the NEOs had above-market earnings on deferred compensation.
5 Please see the table below for information on the numbers that comprise the All Other Compensation column.
ALL OTHER COMPENSATION | ||||||||||||||
Name and Principal Position |
Year | Retirement ($) |
Executive Group Life Insuranceii ($) |
Flexible Compensation Program Contributionsiii ($) |
Expatriate, Relocation and Tax Equalization Paymentsiv ($) |
Executive Benefitsv ($) |
Totalvi ($) | |||||||
David Taylor |
||||||||||||||
Chairman of the |
201819 | 55,555 | 13,776 | 5,450 | 0 | 345,250 | 420,031 | |||||||
Board, President |
201718 | 54,157 | 9,384 | 5,350 | 0 | 181,996 | 250,887 | |||||||
and Chief Executive |
201617 | 52,648 | 5,177 | 5,300 | 0 | 125,738 | 188,863 | |||||||
Jon R. Moeller |
201819 | 55,555 | 9,314 | 5,450 | 0 | 15,620 | 85,939 | |||||||
Vice Chairman and |
201718 | 54,157 | 7,710 | 5,350 | 0 | 43,060 | 110,277 | |||||||
Chief Financial Officer |
201617 | 52,648 | 6,281 | 5,300 | 0 | 10,955 | 75,184 | |||||||
Mary Lynn |
||||||||||||||
Ferguson-McHugh |
||||||||||||||
Group President |
201819 | 55,555 | 4,507 | 5,450 | 0 | 10,229 | 75,741 | |||||||
Global Family Care |
201718 201617 |
54,157 52,648 |
3,025 1,741 |
5,350 5,300 |
0 1,187 |
5,335 19,453 |
67,867 80,329 | |||||||
Deborah P. Majoras |
||||||||||||||
Chief Legal Officer and Secretary
|
201819 | 79,750 | 7,353 | 3,413 | 0 | 0 | 90,516 | |||||||
Carolyn M. Tastad |
||||||||||||||
Group President North America Selling and Market Operations
|
201819 | 55,555 | 7,759 | 5,450 | 0 | 12,190 | 80,954 |
i Amounts contributed by the Company pursuant to the PST, a qualified defined contribution plan providing retirement benefits for U.S.-based employees. NEOs also receive contributions in the form of RSU grants pursuant to the PST Restoration
48 The Procter & Gamble Company | ||
EXECUTIVE COMPENSATION | ||
Program, a nonqualified defined contribution plan. Ms. Majoras also received retirement benefit contributions in the form of RSU grants pursuant to the Supplemental Retirement Income Program, a nonqualified defined contribution plan. These RSU awards are included in the Stock Awards column of the Summary Compensation Table.
ii Under the Executive Group Life Insurance Program (EGLIP), the Company offers key executives who have substantially contributed to the success and development of the business, and upon whom the future of the Company chiefly depends, life insurance coverage equal to salary plus their STAR target up to a maximum of $5,000,000. These policies are owned by the Company. Because premium payments are returned to the Company when the benefit is paid out, we believe the annual premiums paid by the Company overstate the Companys true cost of providing this life insurance benefit. Accordingly, the amounts shown in the table are an average based on Internal Revenue Service tables used to value the term cost of such coverage for calendar year 2018 and calendar year 2019, which reflect what it would cost the executive to obtain the same coverage in a term life insurance policy. The average of the two calendar years was used because fiscal year data is not available. The average of the dollar value of the premiums actually paid by the Company in calendar years 2018 and 2019 under these policies were as follows: Mr. Taylor, $73,786, Mr. Moeller, $83,145, Ms. Ferguson-McHugh, $79,542, Ms. Majoras, $59,931, and Ms. Tastad, $67,842 . This program is in addition to any other Company-provided group life insurance in which an NEO may enroll that is also available to all employees on the same basis.
iii Flexible Compensation Program Contributions are given in the form of credits to pay for coverage in a number of benefit plans including, but not limited to, medical insurance and additional life insurance. Employees may also receive unused credits as cash. Credits are earned based on PST years of service.
iv The Company provides assistance to certain employees, including NEOs, related to expenses incurred in connection with expatriate assignments and Company-required relocations. The Company did not pay any such assistance to the NEOs in FY 2018-19.
v In addition, all NEOs are entitled to the following personal benefits: financial counseling (including tax preparation), an annual physical examination, occasional use of a Company car, secure workplace parking, and home security and monitoring. The costs associated with Mr. Taylors use of a Company car were $23,228. The costs associated with home security and monitoring for Mr. Taylor were $54,384. While Company aircraft is generally used for Company business only, the CEO is required to use Company aircraft for all air travel, including travel to outside board meetings and personal travel, pursuant to the Companys executive security program established by the Board of Directors. While traveling on Company aircraft, the CEO and Chairman of the Board may bring a limited number of guests (spouse, family member, or similar guest) to accompany him. The aggregate incremental aircraft usage costs associated with Mr. Taylors personal use of the Company aircraft during FY 2018-19 were $261,820. Mr. Moeller, Ms. Ferguson-McHugh, Ms. Majoras, and Ms. Tastad are permitted to use the Company aircraft for travel to outside board meetings and, if the Company aircraft is already scheduled for business purposes and can accommodate additional passengers, may use it for personal travel and guest accompaniment. The aggregate incremental aircraft usage costs associated with Mr. Moellers personal use of the Company aircraft were $5,320 and for Ms. Tastad were $2,040. None of the other NEOs used the Company aircraft for these purposes in FY 2018-19. The incremental costs to the Company for these benefits, other than use of Company aircraft, are the actual costs or charges incurred by the Company for the benefits. The incremental cost to the Company for use of the Company aircraft is calculated by using an hourly rate for each flight hour. The hourly rate is based on the variable operational costs of each flight, including fuel, maintenance, flight crew travel expense, catering, communications and fees, including flight planning, ground handling and landing permits. For any flights that involved mixed personal and business usage, any personal usage hours that exceed the business usage are utilized to determine the incremental cost to the Company.
vi This total does not reflect a charitable donation of $10,000 made by the Company to the Childrens Safe Drinking Water Program on behalf of the Companys Global Leadership Council, of which each NEO is a member. This donation was funded from general corporate assets, and the NEOs derived no financial benefits from this donation because this charitable deduction accrues solely to the Company.
2019 Proxy Statement 49 | ||||
EXECUTIVE COMPENSATION | ||
The following table and footnotes provide information regarding grants of equity under Company plans made to the NEOs during FY 2018-19.
GRANTS OF PLAN-BASED AWARDS |
||||||||||||||||||||||||||||||||
Name/Plan |
Grant |
Compensation & Leadership Development Committee Action Date |
Estimated Future Payouts Under Equity Incentive Plan Awards |
All Number Shares Stock (#) |
All Other of Securities Underlying Options (#) |
Exercise of Option Awards2 ($ per share) |
Grant Date Fair Value of Stock and Option Awards3 ($) |
|||||||||||||||||||||||||
Threshold (#) |
Target (#) |
Maximum (#) |
||||||||||||||||||||||||||||||
David Taylor |
||||||||||||||||||||||||||||||||
LTIP Options4 |
02/28/2019 | 02/12/2019 | 230,586 | 98.55 | 3,251,263 | |||||||||||||||||||||||||||
LTIP RSUs5 |
02/28/2019 | 02/12/2019 | 31,698 | 3,123,838 | ||||||||||||||||||||||||||||
PSUs6 |
02/28/2019 | 02/12/2019 | 0 | 55,716 | 111,432 | 6,375,025 | ||||||||||||||||||||||||||
PST Restoration RSUs7 |
08/02/2018 | 06/12/2018 | 3,457 | 269,255 | ||||||||||||||||||||||||||||
STAR Stock Options8 |
09/14/2018 | 08/14/2018 | 143,748 | 83.61 | 1,641,602 | |||||||||||||||||||||||||||
Jon R. Moeller |
||||||||||||||||||||||||||||||||
LTIP Options4 |
02/28/2019 | 02/12/2019 | 160,153 | 98.55 | 2,258,157 | |||||||||||||||||||||||||||
LTIP RSUs5 |
02/28/2019 | 02/12/2019 | 7,638 | 752,725 | ||||||||||||||||||||||||||||
PSUs6 |
02/28/2019 | 02/12/2019 | 0 | 26,315 | 52,630 | 3,010,962 | ||||||||||||||||||||||||||
PST Restoration RSUs7 |
08/02/2018 | 06/12/2018 | 1,898 | 147,830 | ||||||||||||||||||||||||||||
Mary Lynn Ferguson-McHugh |
||||||||||||||||||||||||||||||||
LTIP Options4 |
02/28/2019 | 02/12/2019 | 54,672 | 98.55 | 770,875 | |||||||||||||||||||||||||||
LTIP RSUs5 |
02/28/2019 | 02/12/2019 | 7,823 | 770,957 | ||||||||||||||||||||||||||||
PSUs6 |
02/28/2019 | 02/12/2019 | 0 | 13,475 | 26,950 | 1,541,810 | ||||||||||||||||||||||||||
PST Restoration RSUs7 |
08/02/2018 | 06/12/2018 | 1,501 | 116,908 | ||||||||||||||||||||||||||||
Deborah P. Majoras |
||||||||||||||||||||||||||||||||
LTIP Options4 |
02/28/2019 | 02/12/2019 | 49,650 | 98.55 | 700,065 | |||||||||||||||||||||||||||
LTIP RSUs5 |
02/28/2019 | 02/12/2019 | 7,104 | 700,099 | ||||||||||||||||||||||||||||
PSUs6 |
02/28/2019 | 02/12/2019 | 0 | 12,237 | 24,474 | 1,400,158 | ||||||||||||||||||||||||||
SRI RSUs9 |
08/02/2018 | 06/12/2018 | 623 | 48,524 | ||||||||||||||||||||||||||||
PST Restoration RSUs7 |
08/02/2018 | 06/12/2018 | 752 | 58,571 | ||||||||||||||||||||||||||||
Carolyn M. Tastad |
||||||||||||||||||||||||||||||||
LTIP Options4 |
02/28/2019 | 02/12/2019 | 26,833 | 98.55 | 378,345 | |||||||||||||||||||||||||||
LTIP RSUs5 |
02/28/2019 | 02/12/2019 | 11,518 | 1,135,099 | ||||||||||||||||||||||||||||
PSUs6 |
02/28/2019 | 02/12/2019 | 0 | 13,227 | 26,454 | 1,513,433 | ||||||||||||||||||||||||||
PST Restoration RSUs7 |
08/02/2018 | 06/12/2018 | 1,109 | 86,377 | ||||||||||||||||||||||||||||
STAR Stock Options8 |
09/14/2018 | 08/14/2018 | 48,232 | 83.61 | 550,809 |
1 Grant dates for equity awards are consistent from year to year, as described on page 45 of this proxy statement.
2 The options granted were awarded using the closing price of the Company stock on the date of the grant.
3 This column reflects the grant date fair value of each award computed in accordance with FASB ASC Topic 718. For stock awards, the actual amount paid will be based on the stock price on the delivery date. For options, the actual amount paid will be determined by multiplying the number of shares acquired by the difference between the market price of the Companys common stock upon exercise and the grant price of the options.
4 These options are forfeitable until the later of retirement eligibility or June 30th after the grant date, and will become exercisable on February 28, 2022, and expire on February 28, 2029.
50 The Procter & Gamble Company | ||
EXECUTIVE COMPENSATION | ||
5 These units are forfeitable until the later of retirement eligibility or June 30th after the grant date, and will deliver in shares on February 28, 2022. These units accumulate dividend equivalents at the same rate as dividends paid on common stock.
6 For awards granted under the Performance Stock Program, see page 41 of the Compensation Discussion & Analysis for applicable performance measures. These units are forfeitable until the later of retirement eligibility or June 30th after the grant date, and will deliver in shares in August 2021 unless elected otherwise by the NEO, subject to applicable tax rules and regulations. These units accumulate dividend equivalents at the same rate as dividends paid on common stock.
7 For awards granted under the PST Restoration Program, dividend equivalents are earned at the same rate as dividends paid on common stock. These units will deliver in shares one year following retirement unless elected otherwise by the NEO, subject to applicable tax rules and regulations.
8 These options are nonforfeitable, and will become exercisable on September 15, 2021, and expire on September 15, 2028.
9 For awards granted under the SRI Program, dividend equivalents are earned at the same rate as dividends paid on common stock. These units will deliver in shares one year following retirement unless elected otherwise by the NEO, subject to applicable tax rules and regulations.
2019 Proxy Statement 51 | ||||
EXECUTIVE COMPENSATION | ||
Outstanding Equity at Fiscal Year End
The following table and footnotes provide information regarding unexercised stock options and stock awards that have not yet vested as of the end of FY 2018-19.
OUTSTANDING EQUITY AT FISCAL YEAR-END | ||||||||||||||||||
Option Awards |
Stock Awards | |||||||||||||||||
Name/Plan |
Grant Date |
Number
of Securities Underlying Unexercised Options Exercisable1 (#) |
Number
of Securities Underlying Unexercised Options Unexercisable1 (#) |
Option Exercise Price ($) |
Option Expiration Date |
Number of Shares or Units of Stock that Have Not Vested2 (#) |
Market Value of Shares or Units of Stock that Have Not Vested3 ($) |
Equity Incentive Plan |
Equity Incentive Plan | |||||||||
David Taylor
|
||||||||||||||||||
Key Manager
|
02/28/2013
|
108,297
|
76.1800
|
02/28/2023
|
||||||||||||||
STAR
|
09/13/2013
|
74,520
|
79.0500
|
09/13/2023
|
||||||||||||||
Key Manager
|
02/28/2014
|
116,960
|
78.6600
|
02/28/2024
|
||||||||||||||
STAR
|
09/15/2014
|
65,054
|
83.8700
|
09/15/2024
|
||||||||||||||
Key Manager
|
02/27/2015
|
176,202
|
85.1300
|
02/27/2025
|
||||||||||||||
STAR
|
09/15/2015
|
68,275
|
69.4500
|
09/15/2025
|
||||||||||||||
Key Manager
|
02/29/2016
|
205,095
|
80.2900
|
02/27/2026
|
||||||||||||||
STAR
|
09/15/2016
|
126,874
|
88.0600
|
09/15/2026
|
||||||||||||||
LTIP
|
02/28/2017
|
280,899
|
91.0700
|
02/26/2027
|
||||||||||||||
STAR
|
09/15/2017
|
315,392
|
93.2700
|
09/15/2027
|
||||||||||||||
LTIP
|
02/28/2018
|
252,017
|
78.5200
|
02/28/2028
|
||||||||||||||
PSP
|
02/28/2018
|
82,881
|
9,088,011
| |||||||||||||||
STAR |
09/14/2018 |
143,748 |
83.6100 |
09/14/2028 |
||||||||||||||
LTIP |
02/28/2019 |
230,586 |
98.5500 |
02/28/2029 |
||||||||||||||
PSP |
02/28/2019 |
56,107 |
6,152,242 | |||||||||||||||
Jon R. Moeller |
||||||||||||||||||
Key Manager |
02/29/2012 |
122,187 |
67.5200 |
02/28/2022 |
||||||||||||||
Key Manager |
02/28/2013 |
127,987 |
76.1800 |
02/28/2023 |
||||||||||||||
Key Manager |
02/28/2014 |
130,626 |
78.6600 |
02/28/2024 |
||||||||||||||
Key Manager |
02/27/2015 |
132,151 |
85.1300 |
02/27/2025 |
||||||||||||||
Key Manager |
02/29/2016 |
150,393 |
80.2900 |
02/27/2026 |
||||||||||||||
LTIP |
02/28/2017 |
190,034 |
91.0700 |
02/26/2027 |
||||||||||||||
LTIP |
02/28/2018 |
169,365 |
78.5200 |
02/28/2028 |
||||||||||||||
PSP |
02/28/2018 |
37,133 |
4,071,633 | |||||||||||||||
LTIP |
02/28/2019 |
160,153 |
98.5500 |
02/28/2029 |
||||||||||||||
PSP |
02/28/2019 |
26,500 |
2,905,725 | |||||||||||||||
Mary Lynn Ferguson-McHugh |
||||||||||||||||||
Key Manager |
02/29/2012 |
37,027 |
67.5200 |
02/28/2022 |
||||||||||||||
Key Manager |
02/28/2013 |
39,381 |
76.1800 |
02/28/2023 |
||||||||||||||
Key Manager |
02/28/2014 |
49,899 |
78.6600 |
02/28/2024 |
||||||||||||||
Special Award |
11/03/2014 |
5,723 |
627,527 |
|||||||||||||||
Key Manager |
02/27/2015 |
48,162 |
85.1300 |
02/27/2025 |
||||||||||||||
Key Manager |
02/29/2016 |
54,802 |
80.2900 |
02/27/2026 |
||||||||||||||
LTIP |
02/28/2017 |
70,693 |
91.0700 |
02/26/2027 |
||||||||||||||
LTIP |
02/28/2018 |
65,596 |
78.5200 |
02/28/2028 |
||||||||||||||
PSP |
02/28/2018 |
21,573 |
2,365,479 | |||||||||||||||
LTIP |
02/28/2019 |
54,672 |
98.5500 |
02/28/2029 |
||||||||||||||
PSP |
02/28/2019 |
13,570 |
1,487,951 |
52 The Procter & Gamble Company | ||
EXECUTIVE COMPENSATION | ||
OUTSTANDING EQUITY AT FISCAL YEAR-END | ||||||||||||||||||
Option Awards |
Stock Awards | |||||||||||||||||
Name/Plan |
Grant Date |
Number
of Securities Underlying Unexercised Options Exercisable1 (#) |
Number
of Securities Underlying Unexercised Options Unexercisable1 (#) |
Option Exercise Price ($) |
Option Expiration Date |
Number of Shares or Units of Stock that Have Not Vested2 (#) |
Market Value of Shares or Units of Stock that Have Not Vested3 ($) |
Equity Incentive Plan |
Equity Incentive Plan | |||||||||
Deborah P. Majoras |
||||||||||||||||||
Key Manager |
02/29/2012 |
88,863 |
67.5200 |
02/28/2022 |
||||||||||||||
Key Manager |
02/28/2013 |
95,170 |
76.1800 |
02/28/2023 |
||||||||||||||
Key Manager |
02/28/2014 |
45,131 |
78.6600 |
02/28/2024 |
||||||||||||||
STAR |
09/15/2014 |
20,964 |
83.8700 |
09/15/2024 |
||||||||||||||
Key Manager |
02/27/2015 |
50,218 |
85.1300 |
02/27/2025 |
||||||||||||||
STAR |
09/15/2015 |
24,075 |
69.4500 |
09/15/2025 |
||||||||||||||
Key Manager |
02/29/2016 |
55,113 |
80.2900 |
02/27/2026 |
||||||||||||||
STAR |
09/15/2016 |
26,736 |
88.0600 |
09/15/2026 |
||||||||||||||
LTIP |
02/28/2017 |
67,299 |
91.0700 |
02/26/2027 |
||||||||||||||
STAR |
09/15/2017 |
56,241 |
93.2700 |
09/15/2027 |
||||||||||||||
LTIP |
02/28/2018 |
58,500 |
78.5200 |
02/28/2028 |
||||||||||||||
PSP |
02/28/2018 |
19,239 |
2,109,666 | |||||||||||||||
LTIP |
02/28/2019 |
49,650 |
98.5500 |
02/28/2029 |
||||||||||||||
PSP |
02/28/2019 |
12,323 |
1,351,217 | |||||||||||||||
Carloyn M. Tastad |
||||||||||||||||||
STAR |
09/13/2013 |
8,145 |
79.0500 |
09/13/2023 |
||||||||||||||
Key Manager |
02/28/2014 |
29,240 |
78.6600 |
02/28/2024 |
||||||||||||||
STAR |
09/15/2014 |
21,496 |
83.8700 |
09/15/2024 |
||||||||||||||
STAR |
09/15/2015 |
30,371 |
69.4500 |
09/15/2025 |
||||||||||||||
STAR |
09/15/2016 |
37,698 |
88.0600 |
09/15/2026 |
||||||||||||||
LTIP |
02/28/2017 |
96,559 |
91.0700 |
02/26/2027 |
||||||||||||||
STAR |
09/15/2017 |
71,929 |
93.2700 |
09/15/2027 |
||||||||||||||
LTIP |
02/28/2018 |
88,106 |
78.5200 |
02/28/2028 |
||||||||||||||
PSP |
02/28/2018 |
19,317 |
2,118,219 | |||||||||||||||
STAR |
09/14/2018 |
48,232 |
83.6100 |
09/14/2028 |
||||||||||||||
LTIP |
02/28/2019 |
26,833 |
98.5500 |
02/28/2029 |
||||||||||||||
PSP |
02/28/2019 |
13,320 |
1,460,538 |
2019 Proxy Statement 53 | ||||
EXECUTIVE COMPENSATION | ||
1 The following provides details regarding the vesting date for each of the option grants included in the table. The Vest Date indicates the date the options become exercisable.
Option Awards | ||||||
Grant Date |
Vest Date |
Grant Date |
Vest Date | |||
02/29/2012 |
02/28/2015 |
02/29/2016 |
02/28/2019 | |||
09/14/2012 |
09/14/2015 |
09/15/2016 |
09/15/2019 | |||
02/28/2013 |
02/28/2016 |
02/28/2017 |
02/28/2020 | |||
09/13/2013 |
09/13/2016 |
09/15/2017 |
09/15/2020 | |||
02/28/2014 |
02/28/2017 |
02/28/2018 |
02/26/2021 | |||
09/15/2014 |
09/15/2017 |
09/14/2018 |
09/14/2021 | |||
02/27/2015 |
02/27/2018 |
02/28/2019 |
02/28/2022 | |||
09/15/2015 |
09/15/2018 |
2 The following provides details regarding the vesting date for RSU and PSU holdings included in the table. The Vest Date for RSUs indicates the date such units become nonforfeitable. The Vest Date for PSUs indicates the date the award is earned. The PSU awards are delivered in shares in August following the date the award is earned after the board certifies payout results.
Stock Awards | ||||
Award Type |
Grant Date |
Vest Date | ||
PSP PSUs |
02/28/2018 |
06/30/2020 | ||
PSP PSUs |
02/28/2019 |
06/30/2021 | ||
Special Equity RSUs |
11/03/2014 |
50% 10/14/2017, 50% 10/14/2019 |
3 The Market Value of PSUs or RSUs that have not vested was determined by multiplying the closing market price of Company stock on June 28, 2019 ($109.65) by the number of PSUs or RSUs, respectively.
54 The Procter & Gamble Company | ||
EXECUTIVE COMPENSATION | ||
Option Exercises and Stock Vested
The following table and footnotes provide information regarding stock option exercises and stock vesting during FY 2018-19 for the NEOs.
OPTION EXERCISES AND STOCK VESTED | ||||||||||||
Option Awards |
Stock Awards | |||||||||||
Name/Plan
|
Option
|
Number of Shares (#)
|
Value Realized
|
Stock Award
|
Number of (#)
|
Value Realized
| ||||||
David Taylor5 |
||||||||||||
Key Manager |
02/26/2010 |
33,113 |
931,121 |
|||||||||
Key Manager |
02/28/2011 |
98,335 |
2,918,906 |
|||||||||
STAR |
09/15/2011 |
16,338 |
520,215 |
|||||||||
Key Manager |
02/29/2012 |
103,673 |
3,733,528 |
|||||||||
STAR |
09/14/2012 |
43,045 |
1,647,355 |
|||||||||
PSP 2016-2019 |
02/28/2017 |
87,089 |
9,549,309 | |||||||||
PST Restoration |
08/02/2018 |
3,457 |
269,255 | |||||||||
LTIP |
02/28/2019 |
31,920 |
3,500,082 | |||||||||
Jon R. Moeller6 |
||||||||||||
Key Manager |
02/26/2010 |
82,965 |
2,372,451 |
|||||||||
Key Manager |
02/28/2011 |
107,058 |
3,086,033 |
|||||||||
Special Award |
08/13/2013 |
6,123 |
498,117 | |||||||||
Key Manager |
02/28/2014 |
8,709 |
858,460 | |||||||||
Key Manager |
02/27/2015 |
8,811 |
962,470 | |||||||||
Key Manager |
02/29/2016 |
10,027 |
1,095,299 | |||||||||
LTIP |
02/28/2017 |
7,984 |
872,103 | |||||||||
PSP 2016-2019 |
02/28/2017 |
39,279 |
4,306,942 | |||||||||
LTIP |
02/28/2018 |
9,284 |
1,014,110 | |||||||||
PST Restoration |
08/02/2018 |
1,898 |
147,830 | |||||||||
LTIP |
02/28/2019 |
7,692 |
843,385 | |||||||||
Mary Lynn Ferguson-McHugh7 |
||||||||||||
Key Manager |
02/26/2010 |
55,310 |
1,563,630 |
|||||||||
Key Manager |
02/28/2011 |
67,407 |
2,501,986 |
|||||||||
PSP 2016-2019 |
02/28/2017 |
21,918 |
2,403,309 | |||||||||
PST Restoration |
08/02/2018 |
1,501 |
116,908 | |||||||||
LTIP |
02/28/2019 |
7,878 |
863,813 | |||||||||
Deborah P. Majoras8 |
||||||||||||
Key Manager |
02/28/2011 |
71,372 |
2,023,361 |
|||||||||
Special Award |
08/13/2013 |
6,123 |
498,107 | |||||||||
Key Manager |
02/28/2014 |
9,027 |
734,662 | |||||||||
Key Manager |
02/27/2015 |
10,044 |
817,431 | |||||||||
Key Manager |
02/29/2016 |
11,023 |
897,107 | |||||||||
LTIP |
02/28/2017 |
8,471 |
689,427 | |||||||||
PSP 2016-2019 |
02/28/2017 |
20,866 |
2,287,957 | |||||||||
LTIP |
02/28/2018 |
9,607 |
781,895 | |||||||||
SRI Program |
08/02/2018 |
623 |
48,524 | |||||||||
PST Restoration |
08/02/2018 |
752 |
58,571 | |||||||||
LTIP |
02/28/2019 |
7,154 |
784,421 |
2019 Proxy Statement 55 | ||||
EXECUTIVE COMPENSATION | ||
OPTION EXERCISES AND STOCK VESTED | ||||||||||||
Option Awards |
Stock Awards | |||||||||||
Name/Plan
|
Option
|
Number of Shares (#)
|
Value Realized
|
Stock Award
|
Number of (#)
|
Value Realized
| ||||||
Carolyn M. Tastad9 |
||||||||||||
STAR |
09/15/2008 |
11,755 |
97,013 |
|||||||||
Key Manager |
02/27/2009 |
16,515 |
542,187 |
|||||||||
STAR |
09/15/2009 |
3,246 |
123,512 |
|||||||||
Key Manager |
02/26/2010 |
12,603 |
373,363 |
|||||||||
Key Manager |
02/28/2011 |
13,888 |
411,982 |
|||||||||
Key Manager |
02/29/2012 |
16,701 |
643,991 |
|||||||||
STAR |
09/14/2012 |
8,944 |
330,212 |
|||||||||
PSP 2016-2019 |
02/28/2017 |
19,958 |
2,188,395 | |||||||||
PST Restoration |
08/02/2018 |
1,109 |
86,377 | |||||||||
LTIP |
02/28/2019 |
11,599 |
1,271,814 |
1 The Number of Shares Acquired on Exercise is the gross number of shares acquired.
2 The Value Realized on Exercise was determined by multiplying the number of shares acquired by the difference between the market price of the Companys common stock upon exercise and the grant price of the options.
3 Numbers of Shares Acquired on Vesting is the gross number of shares acquired. Please see footnote 2 in the Outstanding Equity at Fiscal Year-End Table for the definition of vesting for Stock Awards.
4 Value Realized on Vesting was determined by multiplying the number of shares acquired by the actual market price obtained or, in the absence of a broker transaction, value was determined by the average of the high and low price on the vesting date. The value of PSUs was determined by multiplying the closing market price of Company stock on June 28, 2019 ($109.56) by the number of PSUs. The market value of the PSUs does not included a final payment of dividend equivalents on the PSUs, which will take place on August 15, 2019, prior to delivery in shares.
5 Mr. Taylors February 2019 LTIP RSU Grant vested June 30, 2019 because he is retirement eligible.
6 Mr. Moellers February 2019 LTIP RSU Grant vested June 30, 2019 because he is retirement eligible. His 2015 and 2016 Key Manager RSU Grants, and his 2017 and 2018 LTIP RSU Grants vested on June 11, 2019 because he became retirement eligible on that day.
7 Ms. Ferguson-McHughs February 2019 LTIP RSU Grant vested June 30, 2019 because she is retirement eligible.
8 Ms. Majoras February 2019 LTIP RSU Grant vested June 30, 2019 because she is retirement eligible. Her 2014, 2015, and 2016 Key Manager RSU Grants, and her 2017 and 2018 LTIP RSU Grants vested on August 10, 2018 because she became retirement eligible on that day.
9 Ms. Tastads February 2019 LTIP RSU Grant vested June 30, 2019 because she is retirement eligible.
The following table and footnotes provide information regarding the Companys pension plans for Ms. Tastad as of the end of FY 2018-19. None of the other NEOs had any such arrangements with the Company.
PENSION BENEFITS | ||||||||
Name |
Plan Name | Number of Years of Credited Service1 |
Present Value of Accumulated Benefit2 ($) |
Payments During ($) | ||||
Carolyn M. Tastad |
The Procter & Gamble Company Global IRA |
16 years, 2 months |
3,071,000 |
|||||
The Procter & Gamble Company Canada Plan |
11 years, 5 months |
347,000 |
1 Numbers in this column are computed as of the same pension plan measurement date used for financial statement reporting purposes for the Companys audited financial statements as found in Note 8 to the Consolidated Financial Statements contained in the Companys 2019 Annual Report on Form 10-K.
56 The Procter & Gamble Company | ||
EXECUTIVE COMPENSATION | ||
2 The following provides the assumptions used in each plan to calculate present value under SEC rules. The actual calculation of Ms. Tastads benefit at the time of her retirement may vary according to the terms of the Global IRA and Canada Plan at the time:
Assumptions
|
Global IRA
|
Canada Plan
| ||
Retirement Age |
60 |
60 (unreduced retirement age) | ||
Discount Rate |
3.41% |
2.97% | ||
Salary Increase Rate |
4.75% |
N/A | ||
Social Security Increase Rate |
2.80% (Canada) |
N/A | ||
Pension Increase Rate |
N/A |
0.50% | ||
Pre-Retirement Decrements |
None |
None | ||
Post-Retirement Mortality Table |
RP 2014 using MP 2018 Projection Scale |
2014 Private Sector Canadian Pensioners Mortality Table, projected generationally using improvement scale MI-2017
|
The following exchange rates as of June 30, 2019, were used to calculate present value:
US$ 0.76359: Canadian Dollar 1.00000
The Procter & Gamble Global International Retirement Arrangement (Global IRA)
The Global IRA is designed to provide a supplemental retirement benefit to certain employees who permanently transfer from one country to another country during the course of their employment with the Company. The Global IRA benefit is intended to supplement the total pension benefits (both Company-provided and government-provided) that such employees earned while working for the Company, in light of salary increases received and retirement benefits provided in the final home country. The program was closed to new participants in 2012. To calculate the Global IRA benefit, first a Global IRA target is calculated using the following formula:
The Global IRA target is converted to a present-day lump sum amount, using discount and mortality rates for the final home country. This lump sum amount is reduced by the present-day value of certain benefits earned while working in previous home countries (such as Company-provided and government-provided pension benefits), as well as other actuarial factors and assumptions which, under Plan rules, may change from time to time. The reduced lump sum amount is the Global IRA benefit.
The Procter & Gamble Company Canada Plan (Canada Plan)
The Canada Plan is a defined benefit plan for Canada-based employees enrolled prior to 1999. The Canada Plan provides for post-retirement benefits based on the employees salary and years of service in Canada. The Canada Plan benefit is calculated in accordance with the following formula:
2019 Proxy Statement 57 | ||||
EXECUTIVE COMPENSATION | ||
The benefit is paid as a monthly pension at retirement. The normal retirement age is 65, and there is a surviving spouse benefit of full pension payments for the first five years after retirement and two-thirds of the pension payment after that.
Nonqualified Deferred Compensation
The following table and footnotes provide information regarding the Companys non-tax-qualified defined contribution and deferred compensation plans for each of the NEOs for FY 2018-19. For a complete understanding of the table and the footnotes, please read the narrative that follows the table.
NONQUALIFIED DEFERRED COMPENSATION | ||||||||||||||
Name |
Plan Name | Aggregate Balance at |
Executive ($) |
Registrant ($) |
Aggregate Earnings in Last FY1 ($) |
Aggregate Withdrawals/ Distributions ($) |
Aggregate Balance at | |||||||
David S. Taylor |
Executive Deferred Compensation Plan |
2,471,245 |
136,800 |
116,084 |
2,742,1292 | |||||||||
Employee Stock and Incentive Compensation Plan3 |
8,547,897 |
3,500,0824 |
3,602,966 |
223,991 |
15,426,9545 | |||||||||
PST Restoration Program |
2,590,978 |
269,2556 |
602,766 |
17,340 |
3,445,6597 | |||||||||
Jon. R. Moeller |
Employee Stock and Incentive Compensation Plan3 |
4,787,3678 |
14,983 |
4,802,350 | ||||||||||
PST Restoration Program |
1,456,056 |
147,8306 |
713,306 |
11,886 |
2,305,3069 | |||||||||
Mary Lynn Ferguson- McHugh |
Employee Stock and Incentive Compensation Plan3 |
3,694,572 |
863,81310 |
1,428,299 |
994,40011 |
4,992,28412 | ||||||||
PST Restoration Program |
1,426,752 |
116,9086 |
688,218 |
7,571 |
2,224,30713 | |||||||||
Deborah P. Majoras |
Executive Deferred Compensation Plan |
690,105 |
35,231 |
725,336 | ||||||||||
Employee Stock and Incentive Compensation Plan3 |
4,704,85314 |
1,184,986 |
1,073,63815 |
4,816,201 | ||||||||||
PST Restoration Program |
286,892 |
58,5716 |
152,911 |
3,826 |
494,548 | |||||||||
SRI Program |
454,165 |
48,52416 |
223,749 |
3,175 |
723,263 | |||||||||
Carolyn M. Tastad |
Employee Stock and Incentive Compensation Plan3 |
3,412,867 |
1,271,81417 |
1,342,953 |
561,92018 |
5,465,714 | ||||||||
International Retirement Plan |
675,119 |
256,875 |
931,994 | |||||||||||
PST Restoration Program |
313,974 |
86,3776 |
176,584 |
5,617 |
571,318 |
1 Because none of the amounts included in this column are above-market earnings under SEC reporting rules, they are not reflected in the Summary Compensation Table.
2 Total includes $391,973 previously reported in Summary Compensation Tables for prior years.
3 Amounts shown include awards granted under the terms of either The Procter & Gamble 2009 Plan or The Procter & Gamble 2014 Plan, depending on which plan was in effect at the time the NEO elected to defer the award.
4 Total reflects the 2019 LTIP Stock Grant which became nonforfeitable on June 30, 2019 because Mr. Taylor is retirement eligible. This award is also reported in the Summary Compensation Table found on page 47 of this proxy statement.
5 Total includes $8,948,188 previously reported in Summary Compensation Tables for prior years.
6 Total reflects registrant contributions in the form of RSUs pursuant to the PST Restoration Program, 100% of which are also reported in the Stock Awards column on the Summary Compensation Table found on page 47 of this proxy statement.
58 The Procter & Gamble Company | ||
EXECUTIVE COMPENSATION | ||
7 Total includes $767,817 previously reported in Summary Compensation Tables for prior years.
8 Total reflects the 2015 and 2016 Key Manager RSU Grants, and 2017 and 2018 LTIP RSU Grants that became non-forfeitable on June 11, 2019 because Mr. Moeller became retirement eligible on that day. Also reflects the 2019 LTIP Stock Grant which became nonforfeitable on June 30, 2019 because Mr. Moeller is retirement eligible. This award is also reported in the Summary Compensation Table found on page 47 of this proxy statement.
9 Total includes $1,075,310 previously reported in Summary Compensation Tables for prior years.
10 Total reflects the 2019 LTIP Stock Grant which became nonforfeitable on June 30, 2019 because Ms. Ferguson-McHugh is retirement eligible. This award is also reported in the Summary Compensation Table found on page 47 of this proxy statement.
11 Total reflects the delivery of a 2014 Key Manager Stock Grant.
12 Total includes $1,571,629 previously reported in Summary Compensation Tables for prior years.
13 Total includes $215,693 previously reported in Summary Compensation Tables for prior years.
14 Total reflects the 2014, 2015, and 2016 Key Manager RSU Grants, and 2017 and 2018 LTIP RSU Grants that became non-forfeitable on August 10, 2018 because Ms. Majoras became retirement eligible on that day. Also reflects the 2019 LTIP Stock Grant which became nonforfeitable on June 30, 2019 because Ms. Majoras is retirement eligible. This award is also reported in the Summary Compensation Table found on page 47 of this proxy statement.
15 Total reflects the delivery of a 2014 Key Manager Stock Grant and taxes withheld from Key Manager and LTIP RSU Grants when Ms. Majoras became retirement eligible.
16 Total reflects registrant contributions in the form of RSUs pursuant to the SRI Program, 100% of which are also reported in the Stock Awards column on the Summary Compensation Table found on page 47 of this proxy statement.
17 Total reflects the 2019 LTIP Stock Grant which became nonforfeitable on June 30, 2019 because Ms. Tastad is retirement eligible. This award is also reported in the Summary Compensation Table found on page 47 of this proxy statement.
18 Total reflects the delivery of a 2014 Key Manager Stock Grant.
2019 Proxy Statement 59 | ||||
EXECUTIVE COMPENSATION | ||
60 The Procter & Gamble Company | ||
EXECUTIVE COMPENSATION | ||
Key Compensation Programs
The following table describes the general treatment of compensation under the Companys key programs under various separation scenarios for all Company employees, including the NEOs.
Compensation Element |
Voluntary Separation or Termination for Cause |
Company Encouraged Separation |
Retirement or Disability |
Change in Control |
Death | |||||
Separation Allowance
|
None
|
Company has discretion to pay up to 1 times salary.
|
None
|
None
|
None
| |||||
STAR
|
No acceleration of awards. Eligible for award only if worked the entire year.
|
No acceleration of awards. Pro-rated payment based on time worked.
|
No acceleration of awards. Pro-rated payment based on time worked.
|
No acceleration of awards. Pro-rated payment based on time worked.
|
No acceleration of awards. Pro-rated payment based on time worked.
| |||||
LTIP Stock Grant
|
All outstanding awards forfeited at separation.
|
No acceleration of option vesting or RSU delivery. All awards are retained subject to original terms, except for the current year grant if separation occurs before June 30.
|
No acceleration of option vesting or RSU delivery. All awards are retained subject to original terms, except for the current year grant if separation occurs before June 30.
|
Vesting accelerated for awards granted under the 2001 plan. For awards granted under the 2009 and 2014 plan, vesting only accelerated if awards not assumed, unless termination without cause or resignation with good reason.
|
Vesting accelerated for all awards.
| |||||
PSP Grant
|
All outstanding awards forfeited at separation.
|
No acceleration of payment. All awards are retained subject to original terms, except for the current year grant if separation occurs before June 30.
|
No acceleration of payment. All awards are retained subject to original terms, except for the current year grant if separation occurs before June 30.
|
Awards paid out at target at time of the Change in Control.
|
No acceleration of payment. All awards are retained subject to original terms.
| |||||
Special Equity Awards
|
Unvested awards are forfeited at separation.
|
Unvested awards are forfeited at separation unless otherwise specified by the CHRO as authorized by the C&LD Committee.
|
Unvested awards are forfeited at separation unless otherwise specified by the CHRO as authorized by the C&LD Committee.
|
Vesting accelerated and award paid at time of the Change in Control if awards not assumed, unless termination without cause or resignation with good reason.
|
Vesting accelerated and award paid at time of death.
|
2019 Proxy Statement 61 | ||||
EXECUTIVE COMPENSATION | ||
Estimated Post-Employment Treatment of Compensation and Benefits
The following table and footnotes quantify the treatment of compensation or value of benefits that each NEO would receive under the Companys compensation programs upon various scenarios for termination of employment or a change in control of the Company. The amounts shown assume the event that triggered the treatment occurred on June 30, 2019.
Name |
Voluntary Separation or Termination for Cause ($) |
Company Encouraged Separation ($) |
Retirement or Disability ($) |
Change in Control ($) |
Death ($) | |||||
David Taylor |
||||||||||
Salary |
0 |
1,700,000 |
0 |
0 |
0 | |||||
STAR1 |
0 |
0 |
0 |
0 |
11,648,529 | |||||
Long-Term Incentive Program2 |
0 |
15,623,897 |
15,623,897 |
15,623,897 |
15,623,897 | |||||
PSP3 |
0 |
15,240,049 |
15,240,049 |
15,240,049 |
15,240,049 | |||||
Executive Group Life Insurance |
0 |
0 |
0 |
0 |
5,100,000 | |||||
Jon R. Moeller |
||||||||||
Salary |
0 |
1,050,000 |
0 |
0 |
0 | |||||
STAR1 |
0 |
0 |
0 |
0 |
0 | |||||
Long-Term Incentive Program2 |
0 |
10,580,862 |
10,580,862 |
10,580,862 |
10,580,862 | |||||
PSP3 |
0 |
6,977,314 |
6,977,314 |
6,977,314 |
6,977,314 | |||||
Special Equity Awards4 |
0 |
0 |
0 |
0 |
0 | |||||
Executive Group Life Insurance |
0 |
0 |
0 |
0 |
2,415,000 |
62 The Procter & Gamble Company | ||
EXECUTIVE COMPENSATION | ||
PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL | ||||||||||
Name |
Voluntary Separation or Termination for Cause ($) |
Company Encouraged Separation ($) |
Retirement or Disability ($) |
Change in Control ($) |
Death ($) | |||||
Mary Lynn Ferguson-McHugh |
||||||||||
Salary |
0 |
880,000 |
0 |
0 |
0 | |||||
STAR1 |
0 |
0 |
0 |
0 |
0 | |||||
Long-Term Incentive Program2 |
0 |
3,962,338 |
3,962,338 |
3,962,338 |
3,962,338 | |||||
PSP3 |
0 |
3,853,332 |
3,853,332 |
3,853,332 |
3,853,332 | |||||
Special Equity Awards4 |
0 |
0 |
0 |
627,527 |
627,527 | |||||
Executive Group Life Insurance |
0 |
0 |
0 |
0 |
1,760,000 | |||||
Deborah P. Majoras |
||||||||||
Salary |
0 |
890,000 |
0 |
0 |
0 | |||||
STAR1 |
0 |
0 |
0 |
0 |
1,498,458 | |||||
Long-Term Incentive Program2 |
0 |
3,622,635 |
3,622,635 |
3,622,635 |
3,622,635 | |||||
PSP3 |
0 |
3,460,771 |
3,460,771 |
3,460,771 |
3,460,771 | |||||
Special Equity Awards4 |
0 |
0 |
0 |
0 |
0 | |||||
Executive Group Life Insurance |
0 |
0 |
0 |
0 |
1,869,000 | |||||
Carolyn M. Tastad |
||||||||||
Salary |
0 |
760,000 |
0 |
0 |
0 | |||||
STAR1 |
0 |
0 |
0 |
0 |
3,248,058 | |||||
Long-Term Incentive Program2 |
0 |
4,834,652 |
4,834,652 |
4,834,652 |
4,834,652 | |||||
PSP3 |
0 |
3,578,650 |
3,578,650 |
3,578,650 |
3,578,650 | |||||
Special Equity Awards4 |
0 |
0 |
0 |
0 |
0 | |||||
Executive Group Life Insurance |
0 |
0 |
0 |
0 |
1,520,000 |
1 STAR awards previously elected in stock options that would vest and become exercisable immediately upon death. No other amounts are included for STAR because the NEO would be entitled to the same payment whether or not separation occurred on June 30, 2019.
2 Upon voluntary separation or termination, all outstanding awards would be forfeited. While all unvested awards are retained (except for the current year grant if separation occurs before June 30) in the event of Company encouraged separation, retirement, or disability, these events do not trigger any change in the original payment terms of the awards. The amounts shown for the LTIP Stock Grant in the event of Company-encouraged separation, retirement or disability represents the value of the unexercisable stock options and undelivered RSUs as of June 30, 2019, that would be retained at separation and payout according to the original terms and timing of the grants. Awards vest and become immediately exercisable in the event of death or change in control with termination for reasons other than cause or for good reason.
3 Upon voluntary separation or termination, all outstanding awards would be forfeited. While all unvested awards are retained (except for the current year grant if separation occurs before June 30) in the event of Company-encouraged separation, retirement or disability, or death, these events do not trigger any change in the original payment terms of the awards. In the event of change in control, PSP will pay out at target on the date of the change in control. The amounts shown for the PSP grants represent the value of the unvested PSUs as of June 30, 2019 that would be retained on the triggering event and pay out according to the original terms and timing of the grants.
4 Upon voluntary separation or termination, all outstanding awards would be forfeited. In the event of Company encouraged separation, retirement or disability, the CHRO has the discretion to allow retention of the awards with delivery under the original payment terms. Awards vest and become immediately deliverable in the event of death or change in control with termination for reasons other than cause or for good reason.
2019 Proxy Statement 63 | ||||
EXECUTIVE COMPENSATION | ||
1 We excluded the following approximate number of employees by jurisdiction: Saudi Arabia, 834; Ukraine, 585; Czech Republic, 555; Pakistan, 413; Nigeria, 363; South Africa, 323; United Arab Emirates, 290; Morocco, 201; Greece, 197; Netherlands, 144; Sweden, 129; Portugal, 84; Kazakhstan, 56; Austria, 47; Israel, 45; Croatia, 44; Kenya, 43; Serbia, 28; Slovakia, 25; Denmark, 24; Finland, 23; Bulgaria, 19; Azerbaijan, 19; Norway, 15; Latvia, 10; Ghana, 8; Algeria, 7; Ethiopia, 3; Luxembourg, 2; Dominican Republic, 2; Bangladesh, 1.
64 The Procter & Gamble Company | ||
BENEFICIAL OWNERSHIP | ||
Security Ownership of Management and Certain Beneficial Owners
The following table shows all entities that are the beneficial owners of more than 5% of any class of the Companys voting securities:
Title of Class
|
Name and Address of Beneficial Owner
|
Amount and Nature
|
Percent of Class
| |||
Common |
BlackRock, Inc. 55 East 52nd Street New York, NY 10055 |
168,407,9781 |
6.80% | |||
Common |
The Vanguard Group 100 Vanguard Blvd. Malvern, PA 19355 |
194,968,0092 |
7.82% |
1 Based on information as of December 31, 2018, contained in a Schedule 13G/A filed with the SEC on February 6, 2019 by BlackRock, Inc. The Schedule 13G/A indicates that BlackRock, Inc. has (i) sole power to vote or direct to vote with respect to 144,718,950 shares, and (ii) sole dispositive power with respect to 168,407,978 shares.
2 Based on information as of December 31, 2018, contained in a Schedule 13G/A filed with the SEC on February 12, 2019 by The Vanguard Group. The Schedule 13G/A indicates that The Vanguard Group has (i) sole power to vote or direct to vote with respect to 2,897,695 shares, (ii) shared voting power with respect to 597,274 shares, (iii) sole dispositive power with respect to 191,536,266 shares, and (iv) shared dispositive power with respect to 3,431,743 shares.
2019 Proxy Statement 65 | ||||
BENEFICIAL OWNERSHIP | ||
The following tables and footnotes provide information regarding the ownership of the Companys Common Stock and Series A and B ESOP Convertible Class A Preferred Stock by all Directors and nominees, each NEO, and all Directors and executive officers as a group on June 30, 2019:
COMMON STOCK |
||||||||||||||
NUMBER OF SHARES/OPTIONS |
||||||||||||||
Amount and Nature of Beneficial Ownership
|
||||||||||||||
Name
|
Direct1
|
Right
to
|
Trusteeships
|
Indirect
|
Total
|
Percent
|
Restricted
| |||||||
Francis S. Blake |
5,466 |
5,466 |
6 |
8,998 | ||||||||||
Angela F. Braly |
9,431 |
9,431 |
6 |
30,202 | ||||||||||
Amy L. Chang |
6 |
4,176 | ||||||||||||
Kenneth I. Chenault |
6,700 |
6,700 |
6 |
34,803 | ||||||||||
Scott D. Cook |
36,409 |
32,656 |
69,065 |
6 |
44,082 | |||||||||
Mary Lynn Ferguson-McHugh7 |
42,748 |
251,540 |
28,491 |
322,779 |
6 |
71,538 | ||||||||
Joseph Jimenez |
12,468 |
12,468 |
6 |
3,789 | ||||||||||
Terry J. Lundgren |
2,736 |
530 |
3,266 |
6 |
20,517 | |||||||||
Deborah P. Majoras |
2,141 |
400,587 |
402,728 |
6 |
55,030 | |||||||||
W. James McNerney, Jr. |
33,545 |
33,545 |
6 |
44,082 | ||||||||||
Jon R. Moeller8 |
129,694 |
810,589 |
940,283 |
6 |
72,504 | |||||||||
Nelson Peltz |
36,628,3679 |
36,628,367 |
1.46% |
2,176 | ||||||||||
Carolyn Tastad10 |
7,206 |
109,561 |
1,993 |
118,760 |
6 |
62,982 | ||||||||
David Taylor |
110,439 |
901,843 |
1,012,282 |
6 |
156,109 | |||||||||
Margaret C. Whitman |
11,075 |
11,075 |
6 |
20,241 | ||||||||||
Patricia A. Woertz |
1,660 |
1,660 |
6 |
29,354 | ||||||||||
Ernesto Zedillo |
5,785 |
5,785 |
6 |
44,895 | ||||||||||
32 Directors and executive officers, as a group
|
684,535
|
6,346,551
|
94,711
|
36,628,367
|
43,754,164
|
1.75%
|
1,020,488
|
1 Includes unrestricted Common Stock over which each Director or executive officer has sole voting and investment power and restricted Common Stock over which they have voting power but no investment power (until restrictions lapse).
2 Common Stock allocated to personal accounts of executive officers under the Retirement Trust pursuant to PST, the Procter & Gamble International Stock Ownership Plan (ISOP), or The Procter & Gamble U.K. 1-4-1 Plan. Plan participants have sole discretion as to voting and, within limitations provided by PST, investment of shares. PST shares are voted by the Trustees in accordance with instructions from participants. If instructions are not received by the Trustees as to the voting of particular shares, shares are to be voted in proportion to instructions actually received from other participants in the Retirement Trust. ISOP and U.K. 1-4-1 shares are voted in accordance with instructions from participants. If instructions are not received as to the voting of particular shares, a vote will not be submitted for those shares.
3 Total includes stock options that have vested or will vest within 60 days, Common Stock pursuant to the PST that will be allocated to personal accounts of executive officers within 60 days, PSP awards (as described beginning on page 41 that will deliver as Common Stock in August 2019, any Restricted Stock that will vest within 60 days, and any RSUs that will deliver as Common Stock within 60 days. The total does not include the final payment of dividend equivalents that will take place on August 15 on PSP awards that will deliver as Common Stock in August.
4 This column includes shares in which voting and/or investment powers are shared. It also includes shares indirectly held through family members who reside in the household of the director or officer.
5 RSUs represent the right to receive unrestricted shares of Common Stock upon the lapse of restrictions, at which point the holders will have a non-forfeitable right to delivery of Common Stock on a specific date in the future. Total includes RSUs that will not deliver as Common Stock within 60 days and any PSP awards that will deliver as RSUs in August 2019. RSUs that will
66 The Procter & Gamble Company | ||
BENEFICIAL OWNERSHIP | ||
not deliver within 60 days of the record date are not considered beneficially owned because holders are not entitled to voting rights or investment control until the shares are delivered. RSUs that will deliver within 60 days are listed in the Right to Acquire column.
6 Excluding Mr. Peltz, less than .041% for any one Director or NEO.
7 Totals include shares, stock options, and RSUs indirectly held by Ms. Ferguson-McHugh through her spouse, who was previously employed by the Company.
8 Totals include shares, stock options, and RSUs indirectly held by Mr. Moeller through his spouse, who is also employed by the Company.
9 These shares are owned by certain funds and investment vehicles (the Trian Funds) managed by Trian Fund Management, L.P. (Trian), an institutional investment manager. None of such shares are held directly by Mr. Peltz. From time to time, certain of these shares are held in the ordinary course of business with other investment securities owned by the Trian Funds in co-mingled margin accounts with a prime broker, which prime broker may, from time to time, extend margin credit to certain Trian Funds, subject to applicable federal margin regulations, stock exchange rules and credit policies. Trian Fund Management GP, LLC, of which Mr. Peltz is a member, is the general partner of Trian, and therefore is in a position to determine the investment and voting decisions made by the Trian Funds. Accordingly, Mr. Peltz and Trian may be deemed to indirectly beneficially own the shares that the Trian Funds directly and beneficially own.
10 Totals include shares, stock options, and RSUs indirectly held by Ms. Tastad through her spouse, who was previously employed by the Company.
SERIES A ESOP CONVERTIBLE |
||||||
CLASS A PREFERRED STOCK |
||||||
NUMBER OF SHARES |
||||||
AMOUNT AND NATURE OF BENEFICIAL OWNERSHIP |
||||||
NAME
|
PROFIT SHARING
|
TRUSTEESHIPS
|
PERCENT OF
| |||
Francis S. Blake |
||||||
Angela F. Braly |
||||||
Amy L. Chang |
||||||
Kenneth I. Chenault |
||||||
Scott D. Cook |
||||||
Mary Lynn Ferguson-McHugh3 |
8,585 |
2 | ||||
Joseph Jimenez |
||||||
Terry J. Lundgren |
||||||
Deborah P. Majoras |
657 |
2 | ||||
W. James McNerney, Jr. |
||||||
Jon R. Moeller4 |
14,221 |
2 | ||||
Nelson Peltz |
||||||
Carolyn Tastad5 |
3,880 |
2 | ||||
David Taylor |
12,622 |
2 | ||||
Margaret C. Whitman |
||||||
Patricia A. Woertz |
||||||
Ernesto Zedillo |
||||||
32 Directors and executive officers, as a group |
111,945 |
2 | ||||
Employee Stock Ownership Trust of The Procter & Gamble Profit Sharing Trust and Employee Stock Ownership Plan P.O. Box 599, Cincinnati, Ohio 45201-0599 (R. L. Antoine, S. P. Donovan, Jr. and R. C. Stewart, Trustees)
|
4,121,1936
|
2019 Proxy Statement 67 | ||||
BENEFICIAL OWNERSHIP | ||
1 Shares allocated to personal accounts of executive officers under the Employee Stock Ownership Trust pursuant to PST. Plan participants have sole discretion as to voting and, within limitations provided by PST, investment of shares. Shares are voted by the Trustees in accordance with instructions from participants. If instructions are not received by the Trustees as to the voting of particular shares, shares are to be voted in proportion to instructions actually received from other participants in the Trust.
2 Less than .042% for any NEO, and for the Directors and executive officers, as a group; by the terms of the stock, only persons who are or have been employees can have beneficial ownership of these shares.
3 Total includes shares indirectly held by Ms. Ferguson-McHugh through her spouse, who was previously employed by the Company.
4 Total includes shares indirectly held by Mr. Moeller through his spouse, who is also employed by the Company.
5 Total includes shares indirectly held by Ms. Tastad through her spouse, who was previously employed by the Company.
6 Unallocated shares. The voting of these shares is governed by the terms of PST, which provides that the Trustees shall vote unallocated shares held by them in proportion to instructions received from Trust participants as to voting of allocated shares. The disposition of these shares in connection with a tender offer would be governed by the terms of PST, which provides that the Trustees shall dispose of unallocated shares held by them in proportion to instructions received from Trust participants as to the disposition of allocated shares.
SERIES B ESOP CONVERTIBLE |
||||||
CLASS A PREFERRED STOCK |
||||||
NUMBER OF SHARES |
||||||
Amount and Nature of Beneficial Ownership
|
||||||
Name
|
Profit Sharing
|
Trusteeships
|
Percent of
| |||
Francis S. Blake |
||||||
Angela F. Braly |
||||||
Amy L. Chang |
||||||
Kenneth I. Chenault |
||||||
Scott D. Cook |
||||||
Mary Lynn Ferguson-McHugh3 |
176 |
2 | ||||
Joseph Jimenez |
||||||
Terry J. Lundgren |
||||||
Deborah P. Majoras |
||||||
W. James McNerney, Jr. |
||||||
Jon R. Moeller |
||||||
Nelson Peltz |
||||||
Carolyn Tastad4 |
275 |
2 | ||||
David Taylor |
193 |
2 | ||||
Margaret C. Whitman |
||||||
Patricia A. Woertz |
||||||
Ernesto Zedillo |
||||||
32 Directors and executive officers, as a group |
1,119 |
2 | ||||
Employee Stock Ownership Trust of The Procter & Gamble Profit Sharing Trust and Employee Stock Ownership Plan P.O. Box 599, Cincinnati, Ohio 45201-0599 (R. L. Antoine, S. P. Donovan, Jr. and R. C. Stewart, Trustees)
|
27,206,2305
|
1 Shares allocated to personal accounts of executive officers under the Employee Stock Ownership Trust pursuant to PST. Plan participants have sole discretion as to voting and, within limitations provided by PST, investment of shares. Shares are voted
68 The Procter & Gamble Company | ||
BENEFICIAL OWNERSHIP | ||
by the Trustees in accordance with instructions from participants. If instructions are not received by the Trustees as to the voting of particular shares, shares are to be voted in proportion to instructions actually received from other participants in the Trust.
2 Less than .0006% for any NEO, and for the Directors and executive officers, as a group; by the terms of the stock, only persons who are or have been employees can have beneficial ownership of these shares.
3 Total includes shares indirectly held by Ms. Ferguson-McHugh through her spouse, who was previously employed by the Company.
4 Total includes shares indirectly held by Ms. Tastad through her spouse, who was previously employed by the Company.
5 Unallocated shares. The voting of these shares is governed by the terms of PST, which provides that the Trustees shall vote unallocated shares held by them in proportion to instructions received from Trust participants as to voting of allocated shares. The disposition of these shares in connection with a tender offer would be governed by the terms of PST, which provides that the Trustees shall dispose of unallocated shares held by them in proportion to instructions received from Trust participants as to the disposition of allocated shares.
Delinquent Section 16(a) Reports
2019 Proxy Statement 69 | ||||
AUDIT COMMITTEE REPORT | ||
70 The Procter & Gamble Company | ||
AUDIT COMMITTEE REPORT | ||
2019 Proxy Statement 71 | ||||
BOARD PROPOSALS | ||
SUMMARY OF THE 2019 PLAN
2019 Proxy Statement 75 | ||||
BOARD PROPOSALS | ||
76 The Procter & Gamble Company | ||
BOARD PROPOSALS | ||
ADDITIONAL EQUITY COMPENSATION PLAN INFORMATION
The following table gives information about the Companys common stock that may be issued upon the exercise of options, warrants and rights under all of the Companys equity compensation plans as of June 30, 2019. The table includes the following plans: The Procter & Gamble 1992 Stock and Incentive Compensation Plan; The Procter & Gamble 2001 Stock and Incentive Compensation Plan; The Procter & Gamble 2003 Non-Employee Directors Stock Plan; The Procter & Gamble 2009 Stock and Incentive Compensation Plan; and The Procter & Gamble 2014 Stock and Incentive Compensation Plan. There are no outstanding awards under equity compensation plans not approved by security holders.
Plan Category
|
Number of securities to be issued upon exercise of outstanding options, warrants, and rights (A)
|
Weighted-average exercise price of outstanding options, warrants, and rights (B)
|
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (A)) (C)
| |||
Equity Compensation Plans approved by security holders
|
||||||
Options
|
164,812,514
|
$79.5921
|
1
| |||
Restricted Stock Units (RSUs)/Performance Stock Units (PSUs)
|
11,579,025
|
1
| ||||
Grand Total
|
176,391,539
|
2
|
1 Only The Procter & Gamble 2014 Stock and Incentive Compensation Plan allows for future grants of securities. The maximum number of shares that may be granted under this plan is 150 million shares. Under the Procter & Gamble 2014 Stock and Incentive Compensation Plan, stock options and stock appreciation rights are counted on a one-for-one basis, while full value awards (such as RSUs and PSUs) are counted as 5 shares for each share recorded. Total shares available for future issuance under this plan is approximately 41 million shares.
2 Weighted average exercise price of outstanding options only.
2019 Proxy Statement 77 | ||||
OTHER MATTERS | ||
78 The Procter & Gamble Company | ||
OTHER MATTERS | ||
2019 Proxy Statement 79 | ||||
EXHIBIT A | ||
A-2 The Procter & Gamble Company | ||
EXHIBIT A | ||
Organic Sales Growth
Total Company
|
Net Sales Growth
|
Foreign Exchange
|
Acquisition & Divestiture
|
Organic Sales
| ||||
FY 2018-19 |
1.3% |
3.6% |
0.2% |
5.1% | ||||
FY 2017-18 |
2.7% |
(1.8)% |
0.4% |
1.3% | ||||
FY 2016-17 |
(0.4)% |
2.0% |
0.4% |
2.0% | ||||
3 Year Compound Annual Growth Rate |
2.8% |
*Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures, the impact from the July 1, 2018 adoption of a new accounting standard for Revenue from Contracts with Customers, the India Goods & Services Tax changes for fiscal 2018 and rounding impacts necessary to reconcile net sales to organic sales.
Adjusted Free Cash Flow
Operating Cash Flow
|
Capital Spending
|
Adjustments to Operating
|
Adjusted Free
| |||||
FY 2018-19 |
$15,242 |
($3,347) |
$235 |
$12,130 | ||||
FY 2017-18 |
14,867 |
(3,717) |
0 |
11,150 | ||||
FY 2016-17 |
12,753 |
(3,384) |
418 |
9,787 | ||||
Three Year Total |
$42,862 |
($10,448) |
$653 |
$33,067 |
(1) Adjustments to Operating Cash Flow relate to tax payments for the transitional tax resulting from the U.S. Tax Act in fiscal 2019 and tax payments for the Beauty Brands divestiture in fiscal 2017.
Adjusted Free Cash Flow Productivity
Adjusted Free
|
Net Earnings
|
Adjustments to Net
|
Net Earnings Excluding
|
Adjusted Free
| ||||||
FY 2018-19 |
$12,130 |
$3,966 |
$7,625 |
$11,591 |
105% | |||||
FY 2017-18 |
11,150 |
9,861 |
845 |
10,706 |
||||||
FY 2016-17 |
9,787 |
15,411 |
(4,990) |
10,421 |
||||||
Three Year Total |
$33,067 |
$29,238 |
$3,480 |
$32,718 |
101% |
(1) Adjustments to Net Earnings relate to the Shave Care impairment charges and the gain on the dissolution of the PGT Healthcare partnership in fiscal 2019, the transitional impacts of the U.S. Tax Act in fiscal 2018, the losses on early extinguishment of debt in fiscal 2018 and 2017 and the gain on the sale of the Beauty Brands business in fiscal 2017.
2019 Proxy Statement A-3 | ||||
EXHIBIT A | ||
Constant Currency Core Before-Tax Operating Profit 3 Year CAGR
|
FY 2018-19
|
FY 2017-18
|
|
| ||||||
Before-Tax Operating Profit |
$5,487 |
$13,363 |
||||||||
Incremental Restructuring |
403 |
725 |
||||||||
Shave Care Impairment |
8,345 |
|||||||||
Rounding |
1 |
|||||||||
Core Before-Tax Operating Profit |
14,236 |
14,088 |
||||||||
Currency impact |
1,195 |
|||||||||
Constant Currency Core Before-Tax Operating Profit |
15,431 |
|||||||||
Percentage change versus the prior period |
9.5% |
|
|
FY 2017-18(1)
|
FY 2016-17(1)
|
| ||||||
Before-Tax Operating Profit |
$13,711 |
$13,955 |
||||||||
Incremental Restructuring |
739 |
399 |
||||||||
Core Before-Tax Operating Profit |
14,450 |
14,354 |
||||||||
Currency impact |
(145) |
|||||||||
Constant Currency Core Before-Tax Operating Profit |
14,305 |
|||||||||
Percentage change versus the prior period |
(0.3)% |
|
|
|
FY 2016-17(1)
|
FY 2015-16(1)
| ||||||
Before-Tax Operating Profit |
$13,955 |
$13,441 | ||||||||
Incremental Restructuring |
399 |
593 | ||||||||
Charges for European Legal Matters |
13 | |||||||||
Core Before-Tax Operating Profit |
14,354 |
14,047 | ||||||||
Currency impact |
532 |
|||||||||
Constant Currency Core Before-Tax Operating Profit |
14,886 |
|||||||||
Percentage change versus the prior period |
6.0% |
|||||||||
3 Year Compound Annual Growth Rate |
5.0% |
(1) The growth rate for FY 2017-18 and FY2016-17 is calculated based on as reported data prior to the July 1, 2018 retrospective adoption of ASU 2017-07, Compensation-Retirement Benefits. The growth rate for FY2018-19 reflects revised balances after the adoption of ASU 2017-17.
A-4 The Procter & Gamble Company | ||
EXHIBIT A | ||
Core EPS Growth
|
|
FY 2018-19
|
FY 2017-18
| |||||
Diluted Net Earnings Per Share attributable to P&G |
$1.43 |
$3.67 | ||||||
Incremental Restructuring |
0.13 |
0.23 | ||||||
Shave Care Impairment |
3.03 |
|||||||
Anti-Dilutive Impacts |
0.06 |
|||||||
Gain on Dissolution of PGT Healthcare Partnership |
(0.13) |
|||||||
Early Debt Extinguishment Charges |
0.09 | |||||||
Transitional Impacts of the U.S. Tax Act |
0.23 | |||||||
Core EPS |
$4.52 |
$4.22 | ||||||
Percentage change vs. prior period |
7% |
NoteAll reconciling items are presented net of tax. Tax effects are calculated consistent with the nature of the underlying transaction.
Core EPS 3 Year CAGR
FY 2018-19
|
FY 2017-18
|
FY 2016-17
|
FY 2015-16
| |||||
Diluted Net Earnings Per Share from Continuing Operations, attributable to P&G |
$1.43 |
$3.67 |
$3.69 |
$3.49 | ||||
Incremental Restructuring |
0.13 |
0.23 |
0.10 |
0.18 | ||||
Transitional Impact of the U.S. Tax Act |
|
0.23 |
|
| ||||
Early Debt Extinguishment Charges |
|
0.09 |
0.13 |
| ||||
Shave Care Impairment |
3.03 |
|
|
| ||||
Anti-Dilutive Impacts |
0.06 |
|
|
| ||||
Gain on Dissolution of PGT Healthcare Partnership |
(0.13) |
|
|
| ||||
Core EPS |
$4.52 |
$4.22 |
$3.92 |
$3.67 | ||||
3 Year Compound Annual Growth Rate |
7.2% |
NoteAll reconciling items are presented net of tax. Tax effects are calculated consistent with the nature of the underlying transaction.
2019 Proxy Statement A-5 | ||||
EXHIBIT B | ||
The Procter & Gamble Company Audit Committee Policies
I. Guidelines for Pre-Approval of Independent Auditor Services
The Audit Committee (the Committee) has adopted the following guidelines regarding the engagement of the Companys independent auditor to perform services for the Company:
2019 Proxy Statement B-1 | ||||
EXHIBIT C | ||
The Procter & Gamble 2019 Stock and Incentive Compensation Plan
ARTICLE 1 ESTABLISHMENT, PURPOSE AND DURATION
1.1 Establishment. The Procter & Gamble Company, an Ohio corporation (the Company), hereby establishes an incentive compensation plan to be known as The Procter & Gamble 2019 Stock and Incentive Compensation Plan (the Plan), as set forth in this document. This Plan permits the grant of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Stock Units, Cash-Based Awards and Other Stock-Based Awards. This Plan shall become effective upon shareholder approval (the Effective Date) and shall remain in effect as provided in Section 1.3.
1.2 Purpose of this Plan. The purposes of the Plan are to strengthen the alignment of interests between those Employees of the Company and its Subsidiaries who are largely responsible for the success of the business as well as Non-employee Directors and the Companys shareholders through ownership behavior and the increased ownership of shares of the Companys common stock, and to encourage Plan Participants to remain in the employ of the Company and its Subsidiaries.
1.3 Duration of this Plan. Unless sooner terminated as provided herein, this Plan shall terminate ten (10) years from the Effective Date. After this Plan is terminated, no Awards may be granted but Awards previously granted shall remain outstanding in accordance with their applicable terms and conditions and this Plans terms and conditions.
ARTICLE 2 DEFINITIONS
Whenever used in this Plan, the following capitalized terms shall have the meanings set forth below.
Annual Award Limits have the meaning set forth in Section 4.4.
Award means, individually or collectively, a grant under this Plan of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Stock Units, Cash-Based Awards or Other Stock-Based Awards, in each case subject to the terms of this Plan.
Award Agreement means either (i) a written or electronic agreement entered into by the Company and a Participant setting forth the terms and provisions applicable to an Award granted under this Plan, including any amendment or modification thereof, or (ii) a written or electronic statement issued by the Company to a Participant describing the terms and provisions of such Award, including any amendment or modification thereof. The Committee shall have the exclusive authority to determine the terms of an Award Agreement evidencing an Award granted under this Plan, subject to the provisions herein. The terms of an Award Agreement need not be uniform among all Participants or among similar types of Awards.
Board means the Board of Directors of the Company.
Cash-Based Award means an Award, denominated in cash, granted to a Participant as described in Article 12.
Cause for purposes of this Plan only means, unless otherwise specified in an Award Agreement, any one of the following:
(a) Participants conviction of or plea of guilty or nolo contendere, or no contest, to a felony;
(b) Participants willful misconduct;
(c) Participants violation of a material written Company policy; or
(d) Participants willful and continued failure or refusal to substantially perform essential job functions.
Change in Control means the occurrence of one or more of the following events:
(a) The acquisition by any Person of beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act) of more than 20% of either (A) the then-outstanding Shares (Outstanding Company Common
2019 Proxy Statement C-1 | ||||
EXHIBIT C | ||
Stock) or (B) the combined voting power of the then-outstanding voting securities of the Company entitled to vote generally in the election of directors (the Outstanding Company Voting Securities); provided, however, that, for purposes of this Section 2.8(a) the following acquisitions shall not constitute a Change in Control:
(i) any acquisition by the Company,
(ii) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company,
(iii) any acquisition by any entity controlled by the Company, or
(iv) any acquisition by any entity pursuant to a transaction that complies with Sections 2.8(c)(i), (ii) and (iii).
(e) Individuals who, as of the Effective Date, constitute the Board (the Incumbent Board) cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a Director subsequent to the Effective Date whose election, or nomination for election by the Companys shareholders, was approved by a vote of at least a majority of the Directors then comprising the Incumbent Board shall be considered as though such individual was a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of Directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board.
(f) Consummation of a reorganization, merger, statutory share exchange or consolidation or similar corporate transaction involving the Company and/or any entity controlled by the Company, or a sale or other disposition of all or substantially all of the assets of the Company, or the acquisition of assets or stock of another entity by the Company or any entity controlled by the Company (each, a Business Combination), in each case, provided, however, that, for purposes of this Section 2.8(c) a Business Combination shall not constitute a Change in Control if following such Business Combination:
(i) all or substantially all of the individuals and entities that were the beneficial owners (within the meaning of Rule 13d-3 under the Exchange Act) of the Outstanding Company Common Stock and Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the then-outstanding shares of common stock and the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the corporation resulting from such Business Combination (including, without limitation, an entity that, as a result of such transaction, owns the Company or all or substantially all of the Companys assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership, immediately prior to such Business Combination of the Outstanding Company Common Stock and Outstanding Company Voting Securities, as the case may be; and
(ii) no Person (excluding any entity resulting from such Business Combination or any employee benefit plan (or related trust) of the Company or such entity resulting from such Business Combination) beneficially owns, directly or indirectly, 20% or more of, respectively, the then-outstanding shares of common stock of the corporation resulting from such Business Combination or the combined voting power of the then-outstanding voting securities of such corporation, except to the extent that such ownership existed prior to the Business Combination; and
(iii) at least a majority of the members of the board of directors of the entity resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement, or of the action of the Board, providing for such Business Combination.
(g) Approval by the shareholders of the Company of a complete liquidation or dissolution of the Company.
Code means the U.S. Internal Revenue Code of 1986, as amended from time to time. For purposes of this Plan, references to sections of the Code shall be deemed to include any applicable regulations thereunder and any successor or similar provision.
Commission means the Securities and Exchange Commission.
C-2 The Procter & Gamble Company | ||
EXHIBIT C | ||
Committee means the Compensation & Leadership Development Committee of the Board or a subcommittee thereof or any other committee designated by the Board to administer this Plan. The members of the Committee shall be appointed from time to time by and shall serve at the discretion of the Board. If the Committee does not exist or cannot function for any reason, the Board may take any action under the Plan that would otherwise be the responsibility of the Committee. The Committee shall be constituted to comply with the requirements of Rule 16b-3 promulgated by the Commission under the Exchange Act, or such rule or any successor rule thereto which is in effect from time to time, and any applicable listing or governance requirements of any securities exchange on which the Companys common shares are listed.
Company means The Procter & Gamble Company and any successor thereto as provided in Section 21.19.
Director means any individual who is a member of the Board of Directors of the Company.
Dividend Equivalent has the meaning set forth in Article 14.
Effective Date has the meaning set forth in Section 1.1.
Employee means any individual performing services for the Company or a Subsidiary and designated as an employee of the Company or the Subsidiary on its payroll records. An Employee shall not include any individual during any period he or she is classified or treated by the Company or Subsidiary as an independent contractor, a consultant or an employee of an employment, consulting or temporary agency or any other entity other than the Company or Subsidiary, without regard to whether such individual is subsequently determined to have been, or is subsequently retroactively reclassified, as a common- law employee of the Company or Subsidiary during such period. An individual shall not cease to be an Employee in the case of (i) any leave of absence approved by the Company or (ii) transfers between locations of the Company, between the Company and any Subsidiaries, or between Subsidiaries. For purposes of Incentive Stock Options, no such leave may exceed 90 days, unless reemployment upon expiration of such leave is guaranteed by statute or contract. If reemployment upon expiration of a leave of absence approved by the Company is not so guaranteed, then three months following the 91st day of such leave, any Incentive Stock Option held by a Participant shall cease to be treated as an Incentive Stock Option and shall be treated for tax purposes as a Nonqualified Stock Option. Neither service as a Director nor payment of a Directors fee by the Company shall be sufficient to constitute employment by the Company.
Exchange Act means the Securities Exchange Act of 1934, as amended from time to time, or any successor act thereto and the rules and regulations promulgated thereto.
Fair Market Value means, as applied to a specific date, the price of a Share that is based on the opening, closing, actual, high, low or average selling prices of a Share reported on any established stock exchange or national market system including without limitation the New York Stock Exchange and the National Market System of the National Association of Securities Dealers, Inc. Automated Quotation System on the applicable date, the preceding trading day, the next succeeding trading day, or an average of trading days, as determined by the Committee in its discretion. Unless the Committee determines otherwise or unless otherwise specified in an Award Agreement, Fair Market Value shall be deemed to be equal to the closing price of a Share on the most recent date on which Shares were publicly traded.
Good Reason means the occurrence, during the two-year period commencing on the date of a Change in Control, of any of the following without a Participants written consent, in each case, when compared to the arrangements in effect immediately prior to the Change in Control:
(a) a material reduction in the Participants total compensation (defined as the sum of base salary, target annual bonus, and target long-term incentive award);
(b) a material diminution in the Participants duties, responsibilities or authority; or
(c) a relocation of more than 50 miles from the Participants principal office location.
Grant Date means the date an Award is granted to a Participant pursuant to the Plan.
Grant Price means the price established at the time of grant of an SAR pursuant to Article 8.
2019 Proxy Statement C-3 | ||||
EXHIBIT C | ||
Incentive Stock Option or ISO means an Option granted pursuant to Article 7 that is designated as an Incentive Stock Option and that is intended to meet the requirements of Code Section 422 or any successor provision.
Non-employee Director means a Director who is not an Employee.
Nonqualified Stock Option means an Award granted pursuant to Article 7 that is not intended to meet the requirements of Code Section 422, or that otherwise does not meet such requirements.
Option means an Award granted pursuant to Article 7, which Award may be an Incentive Stock Option or a Nonqualified Stock Option.
Option Price means the price at which a Share may be purchased by a Participant pursuant to an Option.
Other Stock-Based Award means an equity-based or equity-related Award not otherwise described by the terms of this Plan that is granted pursuant to Article 12.
Participant means any eligible individual as set forth in Article 5 to whom an Award is granted.
Performance Stock Unit means an Award granted pursuant to Article 11.
Period of Restriction means the period when Restricted Stock or Restricted Stock Units are subject to a substantial risk of forfeiture (based on the passage of time, the achievement of performance goals or upon the occurrence of other events as determined by the Committee, in its discretion) as provided in Articles 9 and 10.
Person shall have the meaning ascribed to such term in Section 3(a) (9) of the Exchange Act and used in Sections 13(d) and 14(d) thereof, including a group as defined in Section 13(d) thereof.
Plan means The Procter & Gamble Company 2019 Stock and Incentive Compensation Plan, as the same may be amended from time to time.
Prior Plans means The Procter & Gamble 2014 Stock and Incentive Compensation Plan, The Procter & Gamble 2009 Stock and Incentive Compensation Plan, and The 2003 Non-Employee Directors Stock Plan.
Restricted Stock means an Award granted pursuant to Article 9.
Restricted Stock Unit or RSU means an Award granted pursuant to Article 10.
Retirement means retirement in accordance with the provisions of any applicable retirement plan of the Company or any of its Subsidiaries as determined in the sole discretion of the Committee or its delegate. If, in the judgement of the Committee or its delegate, the meaning of Retirement under any applicable retirement plan is not determinable, then the meaning of Retirement shall be determined in the sole discretion of the Committee or its delegate.
Share means a share of common stock of the Company.
Stock Appreciation Right or SAR means an Award granted pursuant to Article 8.
Subsidiary means any corporation or other entity, whether domestic or foreign, in which the Company has or obtains, directly or indirectly, an interest of more than 50% by reason of stock ownership or otherwise. In addition, the Board may designate for participation in the Plan as a Subsidiary those additional companies affiliated with the Company in which the Companys direct or indirect interest is less than 50%, provided, however, that such designation shall not be permitted for the granting of Incentive Stock Options and such designation shall not include a company with respect to which the Company is not an eligible issuer of service recipient stock within the meaning of the regulations under Code Section 409A.
Termination of Employment means the termination of the Participants employment with the Company and the Subsidiaries, regardless of the reason for the termination of employment. With respect to any Award that is subject to Code Section 409A, Termination of Employment shall mean a separation from service as defined in Code Section 409A.
Termination of Directorship means the time when a Non-employee Director ceases to be a Non-employee Director for any reason, including, but not by way of limitation, a termination by resignation, failure to be elected,
C-4 The Procter & Gamble Company | ||
EXHIBIT C | ||
death or retirement. With respect to any Award that is subject to Code Section 409A, Termination of Directorship shall mean a separation from service as defined in Code Section 409A.
ARTICLE 3 ADMINISTRATION
3.1 General. The Committee shall be responsible for administering this Plan, subject to this Article 3 and the other provisions of this Plan. The Committee may employ attorneys, consultants, accountants, agents and other individuals, any of whom may be an Employee, and the Committee, the Company, and its officers and Directors shall be entitled to rely upon the advice, opinions or valuations of any such individuals. The Committee may also establish regulations, provisions, and procedures within the terms of the Plan, as may, in its sole discretion, be advisable for the administration and operation of the Plan. All actions taken and all interpretations and determinations made by the Committee shall be final and binding upon the Participants, the Company or Subsidiary, and all other interested individuals.
3.2 Authority of the Committee. Subject to any express limitations set forth in the Plan, the Committee shall have full and exclusive discretionary power and authority to take such actions as it deems necessary and advisable with respect to the administration of the Plan including, but not limited to, the following:
(a) To determine from time to time which of the persons eligible under the Plan shall be granted Awards, when and how each Award shall be granted, what type or combination of types of Awards shall be granted, the provisions of each Award granted (which need not be identical), including the time or times when a person shall be permitted to receive Shares pursuant to an Award and the number of Shares subject to an Award;
(b) To construe and interpret the Plan and Awards granted under it, and to establish, amend, and revoke rules and regulations for its administration. The Committee, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan or in an Award Agreement, in a manner and to the extent it shall deem necessary or expedient to make the Plan fully effective;
(c) To approve forms of Award Agreements for use under the Plan;
(d) To determine Fair Market Value of a Share in accordance with the definition of Fair Market Value in Article 2 of the Plan;
(e) To amend the Plan or any Award Agreement as provided in the Plan;
(f) To adopt sub-plans and/or special provisions applicable to Awards regulated by the laws of a jurisdiction other than the United States. Such sub-plans and/or special provisions may take precedence over other provisions of the Plan, but unless otherwise superseded by the terms of such sub-plans and/or special provisions, the provisions of the Plan shall govern;
(g) To authorize any person to execute on behalf of the Company any instrument required to effect the grant of an Award previously granted by the Board;
(h) To determine whether Awards will be settled in Shares, cash or in any combination thereof;
(i) To determine whether Awards will provide for Dividend Equivalents;
(j) To establish a program whereby Participants designated by the Committee may reduce compensation otherwise payable in cash in exchange for Awards under the Plan;
(k) To impose such restrictions, conditions or limitations as it determines appropriate as to the timing and manner of any sales or other subsequent transfers of any Shares by a Participant, including, without limitation, restrictions under an insider trading policy and restrictions as to the use of a specified brokerage firm for such resales or other transfers;
(l) To authorize the Company to charge a reasonable administrative fee for the exercise of any Option; and
(m) To waive the requirements of Article 6 at the time an Award is granted.
3.3 Delegation. To the extent permitted by law, the Committee may delegate to the Secretary of the Company or other employees of the Company the duties or powers it may deem advisable to assist the Committee in the
2019 Proxy Statement C-5 | ||||
EXHIBIT C | ||
administration and operation of the Plan and may grant authority to such persons to execute documents on behalf of the Committee. To the extent permitted by applicable law, the Committee may, by resolution, authorize one or more officers of the Company to do one or both of the following on the same basis as can the Committee: (a) designate Employees to be recipients of Awards; and (b) determine the size of any such Awards; provided, however, (i) the Committee shall not delegate such responsibilities to any such officer for Awards granted to an Employee who is considered an officer (as defined in Rule 16a-1(f)) of the Exchange Act; (ii) the resolution providing such authorization sets forth the total number of Awards such officer(s) may grant; and (iii) the officer(s) shall report periodically to the Committee regarding the nature and scope of the Awards granted pursuant to the authority delegated.
ARTICLE 4 SHARES SUBJECT TO THIS PLAN AND MAXIMUM AWARDS
4.1 Number of Shares Authorized and Available for Awards. Subject to adjustment as provided under the Plan, the total number of Shares that are available for Awards under this Plan shall be 150,000,000 Shares plus any Shares that are available for Awards under The Procter & Gamble 2014 Stock and Incentive Compensation Plan as of the Effective Date. No further Awards may be granted under the Prior Plans as of the Effective Date.
4.2 Share Usage. The Committee shall determine the method for calculating the number of Shares available for grant under the Plan, subject to the following:
(a) all Options and Stock Appreciation Rights shall be counted against Shares available on a one for one basis;
(b) all full value Awards to be settled in Shares shall be counted as 5 Shares for each Share awarded;
(c) except as provided in clause (d), any Shares that are related to an Award granted under this Plan or Prior Plans that terminates by expiration, forfeiture, cancellation or otherwise without the issuance of the Shares, are settled in cash in lieu of Shares, or is exchanged with the Committees permission, prior to the issuance of Shares, for an Award not involving Shares shall be available again for grant under this Plan;
(d) any Award Shares tendered, exchanged or withheld to cover Option exercise costs, any Award Shares withheld to cover taxes, and all Shares underlying an Award of Stock Appreciation Rights once such Stock Appreciation Rights are exercised, shall be taken into account as Shares issued under this Plan; and
(e) any Award Shares granted by the Company in assumption of, or in substitution or exchange for, awards previously granted by a company acquired by the Company or a Subsidiary, or with which the Company or a Subsidiary combines, shall not reduce the maximum aggregate number of Shares available for issuance under the Plan (to the extent permitted under applicable stock exchange rules), and available shares of stock under a shareholder-approved stock compensation plan of any such acquired company or company with which the Company or a Subsidiary combines (as adjusted to reflect the transaction) may be used for Awards under the Plan and shall not reduce the number of Shares available under the Plan (to the extent permitted by applicable stock exchange rules).
4.3 Shares Subject to Use Under the Plan. The source of the Shares to be delivered by the Company upon exercise or payment of any Award shall be determined by the Committee and may consist, in whole or in part, of authorized but unissued Shares, treasury Shares, or Shares acquired in the open market. In the case of redemption of SARs by one of the Companys Subsidiaries, such Shares shall be Shares acquired by that Subsidiary.
4.4 Annual Award Limits. Awards under the Plan shall be subject to the following Annual Award Limits, subject to any adjustment under Section 4.5. The maximum number of Shares with respect to which Options or other Awards may be granted to any Non-employee Director in any calendar year shall not exceed 10,000. The maximum number of Shares with respect to which Options or SARs may be granted to any Employee who is a Participant in any calendar year shall be 2,000,000 Shares. For any Awards other than Options or SARs and that are denominated in Shares, the maximum aggregate number of Shares that may be delivered pursuant to such Awards granted in any calendar year shall be 400,000 Shares for any Employee who is a Participant. For any Awards that are denominated in cash, the maximum aggregate amount of cash that may be paid with respect to all such Awards granted in any calendar year shall be $20,000,000 for any Employee who is a Participant.
C-6 The Procter & Gamble Company | ||
EXHIBIT C | ||
4.5 Adjustments in Authorized Shares. Adjustments in authorized Shares available for issuance under the Plan or under an outstanding Award and adjustments in Annual Award Limits shall be subject to the following provisions:
(a) In the event of any corporate event or transaction such as a merger, consolidation, reorganization, recapitalization, separation, partial or complete liquidation, stock dividend, stock split, reverse stock split, split up, spin-off, distribution of stock or property of the Company, combination of Shares, exchange of Shares, dividend in kind, extraordinary cash dividend or any other similar corporate event or transaction (Corporate Transaction), the Committee, in order to prevent dilution or enlargement of Participants rights under this Plan, shall substitute or adjust, as applicable, (i) the number and kind of Shares that may be issued under this Plan or under particular forms of Awards, (ii) the number and kind of Shares subject to outstanding Awards, (iii) the Option Price or Grant Price applicable to outstanding Awards, and (iv) the Annual Award Limits and other value determinations applicable to outstanding Awards. The Committee, in its discretion, shall determine the methodology or manner of making such substitution or adjustment.
(b) In addition to the adjustments permitted under paragraph (a) above, the Committee, in its sole discretion, may make such other adjustments or modifications in the terms of any Awards that it deems appropriate to reflect any Corporate Transaction, including, but not limited to, modifications of performance goals and changes in the length of performance periods, provided that no such adjustment or modification shall have the effect of materially and adversely reducing Participants rights and opportunities with respect to outstanding Awards.
(c) The determination of the Committee as to the foregoing adjustments, if any, shall be conclusive and binding on Participants under this Plan.
ARTICLE 5 ELIGIBILITY AND PARTICIPATION
5.1 Eligibility to Receive Awards. Individuals eligible to participate in this Plan include all Employees and Non-employee Directors.
5.2 Participation in the Plan. Subject to the provisions of this Plan, the Committee may, from time to time, select from all individuals eligible to participate in the Plan:
(a) Non-employee Directors, and
(b) those Employees who, in the opinion of the Committee, have demonstrated a capacity for contributing in a substantial manner to the success of the Company and its Subsidiaries,
to whom Awards shall be granted and shall determine, in its sole discretion, the nature of any and all terms permissible by law and the amount of each Award.
ARTICLE 6 RESTRICTIONS AND COVENANTS
6.1 Participant Obligations. In addition to such other conditions as may be established by the Committee, in consideration of the granting of an Award under the terms of the Plan, each Employee who is a Participant agrees as follows. Notwithstanding the foregoing, at any time during which a Participant resides in California, (i) Sections 6.1(a), (b), and (c) shall not apply to such Participant, and (ii) Section 6.1(d) shall not apply to such Participant to the extent that it would impose restrictions similar to Sections 6.1(b) and (c) following the Participants Termination of Employment. Also, notwithstanding the foregoing, at any time during which a Participant resides in Massachusetts, Section 6.1(b) shall apply, but shall be limited to a period of one (1) year following the date of the Participants Termination of Employment.
(a) The right to exercise any Option or Stock Appreciation Right shall be conditional upon certification by the Participant at time of exercise whether the Participant either intends to remain in the employ of the Company or one of its Subsidiaries for at least one (1) year following the date of exercise of the Option or SAR or intends to leave the Company or one of its Subsidiaries within one (1) year following the date of exercise of the Option or SAR, but has no intention to engage in any activity that would violate the non-compete provisions of Article 6.
(b) To better protect the goodwill of the Company and its affiliates and Subsidiaries and to prevent the disclosure of the Companys or its affiliates or Subsidiaries confidential and proprietary trade secret
2019 Proxy Statement C-7 | ||||
EXHIBIT C | ||
information and thereby help ensure the long-term success of the business, the Participant, without prior written consent of the Chief Human Resources Officer and Chief Legal Officer of the Company, will not engage in any activity or provide any services, whether as a director, owner (other than as a passive investor holding less than 5% of an enterprise), manager, supervisor, employee, adviser, consultant or otherwise, for a period of two (2) years following the date of the Participants Termination of Employment, in connection with the manufacture, development, advertising, promotion, or sale of any product which is the same as or similar to or competitive with any products of the Company or its affiliates or Subsidiaries (including both existing products as well as products known to the Participant, as a consequence of the Participants employment with the Company or one of its affiliates or Subsidiaries, to be in development) in any jurisdiction throughout the world, it being acknowledged that the Companys business activities are global in nature:
(i) with respect to which the Participants work has been directly concerned at any time during the two (2) years preceding Termination of Employment, or
(ii) with respect to which the Participant, as a consequence of the Participants job performance and duties, acquired knowledge of confidential and proprietary trade secret information of the Company or its affiliates or Subsidiaries.
For purposes of this Section 6.1(b), it shall be conclusively presumed that Participants have knowledge of information they were directly exposed to through actual receipt or review of memos or documents containing such information, or through actual attendance at meetings at which such information was discussed or disclosed.
(c) To better protect the Companys investment in its employees and to ensure the long-term success of the business, the Participant, without prior written consent of the Company, will not attempt, directly or indirectly, to induce any employee of the Company or its affiliates or Subsidiaries to be employed or perform services elsewhere or attempt directly or indirectly to solicit the trade or business of any customer or partner of the Company or its affiliates or Subsidiaries for a period of five (5) years following the date of the Participants Termination of Employment.
(d) Subject to the provisions of Section 6.1(h), because a main purpose of the Plan is to strengthen the alignment of interests between employees of the Company (including all affiliates and Subsidiaries) and its shareholders to ensure the continued success of the Company, the Participant will not take any action that is significantly contrary to the best interests of the Company or its affiliates or Subsidiaries. For purposes of this Section 6.1(d), an action taken significantly contrary to the best interests of the Company or its affiliates or Subsidiaries includes without limitation any action taken or threatened by the Participant that the Committee determines has, or is reasonably likely to have, a significant adverse impact on the reputation, goodwill, stability, operation, personnel retention and management, or business of the Company or any affiliate or Subsidiary.
(e) Subject to the provisions of Section 6.1(h), the provisions of this Article 6 are not in lieu of, but are in addition to, the continuing obligation of the Participant (which the Participant acknowledges by accepting any Award under the Plan) to not use or disclose the Companys or its affiliates or Subsidiaries confidential and proprietary trade secret information known to the Participant until any particular confidential and proprietary trade secret information becomes generally known (through no fault of the Participant), whereupon the restriction on use and disclosure shall cease as to that item. Information regarding products in development, in test marketing or being marketed or promoted in a discrete geographic region, which information the Company or one of its affiliates or Subsidiaries is considering for broader use, shall not be deemed generally known until such broader use is actually commercially implemented. As used in this Article 6, generally known means known throughout the domestic U. S. industry or, in the case of Participants who have job responsibilities outside of the United States, the appropriate foreign country or countries industry.
(f) Subject to the provisions of Section 6.1(h), by acceptance of any Award granted under the terms of the Plan, the Participant acknowledges that if the Participant were, without authority, to use or disclose the Companys or any of its affiliates or Subsidiaries confidential and proprietary trade secret information or threaten to do so or violate or threaten to violate any other covenant of this Article 6, the Company or one of its affiliates or
C-8 The Procter & Gamble Company | ||
EXHIBIT C | ||
Subsidiaries would be entitled to injunctive and other appropriate relief to prevent the Participant from doing so. The Participant acknowledges that the harm caused to the Company by the breach or anticipated breach of this Article 6 is by its nature irreparable because, among other things, it is not readily susceptible of proof as to the monetary harm that would ensue. The Participant consents that any interim or final equitable relief entered by a court of competent jurisdiction shall, at the request of the Company or one of its affiliates or Subsidiaries, be entered on consent and enforced by any court having jurisdiction over the Participant, without prejudice to any rights either party may have to appeal from the proceedings which resulted in any grant of such relief.
(g) Subject to the provisions of Section 6.1(h), the Participant acknowledges that if the Participant is subject to the Companys Executive Officer Recoupment Policy or any successor policy, then such policy applies with respect to Awards under this Plan and is in addition to all other restrictions and remedies set forth in this Article 6.
(h) Notwithstanding the requirements of confidentiality contained in this Article 6, the federal Defend Trade Secrets Act of 2016 immunizes the Participant against criminal and civil liability under federal or state trade secret laws for Participants disclosure of trade secrets that is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney solely for the purpose of reporting or investigating a suspected violation of law; (ii) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal; or (iii) to the Participants attorney for use in a lawsuit alleging retaliation for reporting a suspected violation of law, provided that any document containing the trade secret is filed under seal and Participant does not otherwise disclose the trade secret, except pursuant to court order. Additionally, nothing contained in this Article 6 prohibits the Participant from: (1) reporting possible violations of federal law or regulations, including any possible securities laws violations, to any governmental agency or entity, including but not limited to the U.S. Department of Justice, the U.S. Securities and Exchange Commission, the U.S. Congress, or any agency Inspector General; (2) making any other disclosures that are protected under the whistleblower provisions of federal law or regulations; or (3) otherwise fully participating in any federal whistleblower programs, including but not limited to any such programs managed by the U.S. Securities and Exchange Commission and/or the Occupational Safety and Health Administration. The Participant does not need prior authorization from the Company to make any such reports or disclosures, and is not required to notify the Company about such disclosures.
(i) If any of the provisions contained in this Article 6 shall for any reason, whether by application of existing law or law which may develop after the Participants acceptance of an Award under the Plan be determined by a court of competent jurisdiction to be overly broad as to scope of activity, duration, or territory, the Participant agrees to join the Company or any of its affiliates or Subsidiaries in requesting such court to construe such provision by limiting or reducing it so as to be enforceable to the extent compatible with then applicable law. If any one or more of the terms, provisions, covenants, or restrictions of this Article 6 shall be determined by a court of competent jurisdiction to be invalid, void or unenforceable, then the remainder of the terms, provisions, covenants, and restrictions of this Article 6 shall remain in full force and effect and shall in no way be affected, impaired, or invalidated.
6.2 Remedies. The Committee may cancel, rescind, suspend, withhold or otherwise limit or restrict any unexpired, unpaid or deferred Awards at any time if the Participant is not in compliance with all terms and conditions set forth in the Plan, including this Article 6. By acceptance of any Award granted under the terms of the Plan, the Participant acknowledges that the remedies outlined in this Section 6.2 and in Section 6.3 below are in addition to any remedy the Company or any affiliate or Subsidiary may have at law or in equity, including without limitation injunctive and other appropriate relief. The Participant further acknowledges that, consistent with Section 6.1(f) above, a breach or anticipated breach of any covenant in this Article 6 will result in irreparable injury to the Company or one of its affiliates or Subsidiaries, for which there is no adequate remedy at law, and that the Company or one of its affiliates or Subsidiaries shall be entitled to obtain from a court of competent jurisdiction a temporary restraining order, a preliminary injunction, and/or a permanent injunction, without proof of actual damages or posting a bond. If a Participant is not in compliance with all terms and conditions set forth in the Plan, including this Article 6, and if litigation or other formal action is required to enforce the Plan, the Company shall be entitled to record its reasonable costs and attorneys fees from the Participant if the Company is the prevailing
2019 Proxy Statement C-9 | ||||
EXHIBIT C | ||
party. The Participant agrees that the Company will be considered the prevailing party for purposes of awarding costs and attorneys fees if the Company obtains any form of partial or complete injunctive relief, whether temporary, preliminary or otherwise.
6.3 Repayment Obligations. Upon exercise, payment or delivery of an Award, the Participant shall certify in a manner acceptable to the Company that he or she has complied with the terms and conditions of the Plan. In the event a Participant fails to comply with any provision in this Article 6 at any time before or after exercise, payment or delivery of an Award, the Participant shall repay to the Company the net proceeds of any exercises, payments or deliveries of Awards which occur at any time after the earlier of the following two dates: (a) the date three (3) years immediately preceding any such violation; or (b) the date six (6) months prior to the Participants Termination of Employment. The Participant shall repay to the Company the net proceeds in such manner and on such terms and conditions as may be required by the Company, and the Company shall be entitled to set-off against the amount of any such net proceeds any amount owed to the Participant by the Company, to the extent that such set-off is not inconsistent with Code Section 409A. For purposes of this paragraph, net proceeds shall mean (1) for each Option or SAR exercise, the difference between the Option Price and the greater of (i) the price of Shares on the date of exercise or (ii) the amount realized upon the disposition of the underlying Shares, less any applicable taxes withheld by the Company; (2) for RSUs or Performance Stock Units, the greater of (i) the number of net Shares delivered to the Participant multiplied by the closing price of Shares on the date of delivery or (ii) the amount realized upon the disposition of the number of net Shares delivered, in either case less any applicable taxes withheld by the Company; (3) for Restricted Stock, the greater of (i) the number of net Shares retained by, or delivered to, the Participant after any restrictions lapse multiplied by the closing price of Shares on the date the restrictions lapse or (ii) the amount realized upon the disposition of the number of net Shares delivered, in either case less any applicable taxes withheld by the Company; and (4) for all other Awards, the value of Shares or cash delivered to the Participant less any applicable taxes withheld by the Company.
6.4 Suspension of Exercise. The Company reserves the right from time to time to suspend the exercise of any Award, where such suspension is deemed by the Company as necessary or appropriate for corporate purposes. No such suspension shall extend the life of the Option or Stock Appreciation Right beyond its expiration date, and in no event will there be a suspension in the five (5) calendar days immediately preceding the expiration date.
ARTICLE 7 STOCK OPTIONS
7.1 Grant of Options. Options may be granted to Participants in such number, and upon such terms, and at any time and from time to time as shall be determined by the Committee, in its sole discretion. Each grant of an Option shall be evidenced by an Award Agreement which shall specify whether the Option is in the form of a Nonqualified Stock Option or an Incentive Stock Option.
7.2 Option Price. The Option Price for each grant of an Option shall be determined by the Committee in its sole discretion and shall be specified in the Award Agreement evidencing such Option; provided, however, the Option Price must be at least equal to 100% of the Fair Market Value of a Share as of the Options Grant Date, subject to adjustment as provided for under Section 4.5.
7.3 Term of Option. The term of an Option granted to a Participant shall be determined by the Committee, in its sole discretion; provided, however, no Option shall be exercisable later than the tenth anniversary of the Grant Date.
7.4 Exercise of Option. An Option shall be exercisable at such times and be subject to such restrictions and conditions as the Committee shall in each instance approve, which terms and restrictions need not be the same for each grant or for each Participant, except that no Option shall be exercisable within one (1) year from its Grant Date, except in the case of the death of the Participant.
7.5 Notice of Exercise. An Option shall be exercised by the delivery of a notice of exercise to the Company or an agent designated by the Company in a form specified or accepted by the Committee, or by complying with any alternative procedures that may be authorized by the Committee, setting forth the number of Shares with respect to which the Option is to be exercised.
C-10 The Procter & Gamble Company | ||
EXHIBIT C | ||
7.6 Payment of Option Price. A condition of the issuance of the Shares as to which an Option shall be exercised shall be the payment of the Option Price. The Option Price of any exercised Option shall be payable to the Company in accordance with one of the following methods:
(a) In cash or its equivalent;
(b) By a cashless (broker-assisted) exercise;
(c) By any combination of (a) and (b); or
(d) Any other method approved or accepted by the Committee in its sole discretion.
Unless otherwise determined by the Committee, all payments under all of the methods indicated above shall be paid in United States dollars or Shares, as applicable.
7.7 Special Rules Regarding ISOs. Notwithstanding any provision of the Plan to the contrary, an Option granted in the form of an ISO to a Participant shall be subject to the following rules. An ISO may be granted solely to eligible Employees of the Company, a parent corporation, or a subsidiary, as defined in Code Section 422. An Award Agreement evidencing the grant of an ISO shall specify that such grant is intended to be an ISO. The Option Price for each grant of an ISO must be at least equal to 100% of the Fair Market Value of a Share as of the ISOs Grant Date (in the case of 10% owners, within the meaning of Code Section 422, the Option Price may not be not less than 110% of such Fair Market Value), subject to adjustment provided for under Section 4.5. Any ISO granted to a Participant shall be exercisable during his or her lifetime solely by such Participant. The period during which a Participant may exercise an ISO shall not exceed ten years (five years in the case of a Participant who is a 10% owner within the meaning of Code Section 422) from its Grant Date. To the extent that the aggregate Fair Market Value of (a) the Shares with respect to which Options are designated as ISOs plus (b) the shares of stock of the Company, parent corporation and subsidiary with respect to which other ISOs are exercisable for the first time by a holder of such ISOs during any calendar year under all plans of the Company, any parent corporation, and any subsidiary exceeds $100,000, such Options shall be treated as Nonqualified Stock Options. For purposes of the preceding sentence, (a) Options shall be taken into account in the order in which they were granted, and (b) the Fair Market Value of the Shares shall be determined as of the time the Option or other ISO is granted. No more than 100,000,000 Shares shall be available under this Plan for delivery with respect to ISOs. No ISO may be granted more than ten years after the earlier of (a) adoption of this Plan by the Board and (b) the Effective Date. No ISO may be sold, transferred, pledged, assigned or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution; provided, however, that at the discretion of the Committee, an ISO may be transferred to a grantor trust under which the Participant making the transfer is the sole beneficiary.
ARTICLE 8 STOCK APPRECIATION RIGHTS
8.1 Grant of SARs. SARs may be granted to Participants in such number, and upon such terms, and at any time and from time to time as shall be determined by the Committee, in its sole discretion. Each grant of SARs shall be evidenced by an Award Agreement.
8.2 Grant Price. The Grant Price for each grant of an SAR shall be determined by the Committee and shall be specified in the Award Agreement evidencing the SAR; provided, however, the Grant Price must be at least equal to 100% of the Fair Market Value of a Share as of the Grant Date, subject to adjustment as provided for under Section 4.5.
8.3 Term of SAR. The term of an SAR granted to a Participant shall be determined by the Committee, in its sole discretion; provided, however, no SAR shall be exercisable later than the tenth anniversary of the Grant Date.
8.4 Exercise of SAR. An SAR shall be exercisable at such times and be subject to such restrictions and conditions as the Committee shall in each instance approve, which terms and restrictions need not be the same for each grant or for each Participant, except that no SAR shall be exercisable within one (1) year from its Grant Date, except in the case of the death of the Participant.
8.5 Notice of Exercise. An SAR shall be exercised by the delivery of a notice of exercise to the Company or an agent designated by the Company in a form specified or accepted by the Committee, or by complying with any alternative procedures that may be authorized by the Committee, setting forth the number of Shares with respect to which the SAR is to be exercised.
2019 Proxy Statement C-11 | ||||
EXHIBIT C | ||
8.6 Settlement of SARs. Upon the exercise of an SAR, pursuant to a notice of exercise properly completed and submitted to the Company in accordance with Section 8.5, a Participant shall be entitled to receive payment from the Company in an amount equal to the product of (a) and (b) below:
(a) The excess of the Fair Market Value of a Share on the date of exercise over the Grant Price.
(b) The number of Shares with respect to which the SAR is exercised.
Payment shall be made in cash, Shares or a combination thereof as provided for under the applicable Award Agreement. In the case of the redemption of SARs by a Subsidiary of the Company not located in the United States, the redemption differential shall be calculated in United States dollars and converted to the appropriate local currency on the exercise date.
ARTICLE 9 RESTRICTED STOCK
9.1 Grant of Restricted Stock. Restricted Stock may be granted to Participants in such number, and upon such terms, and at any time and from time to time as shall be determined by the Committee, in its sole discretion. Each grant of Restricted Stock shall be evidenced by an Award Agreement.
9.2 Nature of Restrictions. Each grant of Restricted Stock shall subject to a Period of Restriction that shall lapse upon the satisfaction of such conditions and restrictions as are determined by the Committee in its sole discretion and set forth in an applicable Award Agreement. Such conditions or restrictions may include, without limitation, one or more of the following:
(a) Restrictions based upon the achievement of specific performance goals; and/or
(b) Time-based restrictions.
9.3 Voting and Dividend Rights. Unless otherwise determined by the Committee and set forth in a Participants applicable Award Agreement, to the extent permitted or required by law, as determined by the Committee, a Participant holding Shares of Restricted Stock granted hereunder shall be granted the right to exercise full voting rights with respect to those Shares and the right to receive dividends declared on those Shares during the Period of Restriction provided, however, that in the case of an Award as to which vesting depends upon the satisfaction of one or more performance conditions, such dividends shall be subject to the same performance conditions as the underlying Award.
ARTICLE 10 RESTRICTED STOCK UNITS
10.1 Grant of Restricted Stock Units. Restricted Stock Units may be granted to Participants in such number, and upon such terms, and at any time and from time to time as shall be determined by the Committee, in its sole discretion. A grant of a Restricted Stock Unit or Restricted Stock Units shall not represent the grant of Shares but shall represent a promise to deliver a corresponding number of Shares or the value of each Share based upon the completion of service, performance conditions, or such other terms and conditions as specified in the applicable Award Agreement over the Period of Restriction. Each grant of Restricted Stock Units shall be evidenced by an Award Agreement.
10.2 Nature of Restrictions. Each grant of Restricted Stock Units shall be subject to a Period of Restriction that shall lapse upon the satisfaction of such conditions and restrictions as are determined by the Committee in its sole discretion and set forth in an applicable Award Agreement. Such conditions or restrictions may include, without limitation, one or more of the following:
(a) Restrictions based upon the achievement of specific performance goals; and/or
(b) Time-based restrictions.
10.3 Voting and Dividend Rights. A Participant shall have no voting or dividend rights with respect to any Restricted Stock Units granted hereunder or the Shares corresponding to any Restricted Stock Units granted hereunder prior to such Shares being delivered to the Participant. A Participant may have a right to Dividend Equivalents based upon the terms of the Award pursuant to Article 14.
10.4 Settlement and Payment of Restricted Stock Units. Unless otherwise determined by the Committee, Restricted Stock Units shall be paid in the form of Shares upon the date specified in the Award Agreement. Any
C-12 The Procter & Gamble Company | ||
EXHIBIT C | ||
Shares paid to a Participant under this Section 10.4 may be subject to any restrictions deemed appropriate by the Committee.
ARTICLE 11 PERFORMANCE STOCK UNITS
11.1 Grant of Performance Stock Units. Performance Stock Units may be granted to Participants in such number, and upon such terms and at any time and from time to time as shall be determined by the Committee, in its sole discretion. A grant of Performance Stock Units shall not represent the grant of Shares but shall represent a promise to deliver Shares or cash based on the satisfaction of performance and, if applicable, service conditions. Each grant of Performance Stock Units shall be evidenced by an Award Agreement.
11.2 Earning of Performance Stock Units. After the applicable performance period has ended, the number of Performance Stock Units earned by the Participant over the performance period shall be determined as a function of the extent to which the applicable corresponding performance goals have been achieved. This determination shall be made solely by the Committee.
11.3 Voting and Dividend Rights. A Participant shall have no voting or dividend rights with respect to any Performance Stock Units granted hereunder or the Shares corresponding to any Performance Stock Units granted hereunder prior to such Shares being delivered to the Participant. A Participant may have a right to Dividend Equivalents based upon the terms of the Award pursuant to Article 14.
11.4 Settlement and Payment of Performance Stock Units. Unless otherwise determined by the Committee, any earned Performance Stock Units shall be paid in the form of Shares following the close of the applicable performance period or at such other time as specified in the Award Agreement. Any Shares paid to a Participant under this Section 11.4 may be subject to any restrictions deemed appropriate by the Committee.
ARTICLE 12 OTHER STOCK-BASED AWARDS AND CASH-BASED AWARDS
12.1 Grant of Other Stock-Based Awards and Cash-Based Awards.
(a) The Committee may grant Other Stock-Based Awards not otherwise described by the terms of this Plan to a Participant in such amounts and subject to such terms and conditions, as the Committee shall determine, in its sole discretion. Such Awards may involve the transfer of actual Shares to Participants, or payment in cash or otherwise of amounts based on the value of Shares.
(b) The Committee may grant Cash-Based Awards not otherwise described by the terms of this Plan to a Participant in such amounts and subject to such terms and conditions, as the Committee shall determine, in its sole discretion.
(c) Each grant of Other Stock-Based Awards and Cash-Based Awards shall be evidenced by an Award Agreement, except to the extent determined by the Committee.
12.2 Value of Other Stock-Based Awards and Cash-Based Awards.
(a) Each Other Stock-Based Award shall be expressed in terms of Shares or units based on Shares, as determined by the Committee, in its sole discretion.
(b) Each Cash-Based Award shall specify a payment amount or payment range as determined by the Committee, in its sole discretion. If the Committee exercises its discretion to establish performance goals, the value of Cash-Based Awards that shall be paid to the Participant will depend on the extent to which such performance goals are met.
12.3 Payment of Other Stock-Based Awards and Cash-Based Awards. Payment, if any, with respect to Cash-Based Awards and Other Stock-Based Awards shall be made in accordance with the terms of the applicable Award Agreement, in cash, Shares or a combination of both as determined by the Committee in its sole discretion.
ARTICLE 13 VESTING
Each Award under this Plan shall be subject to a vesting period of at least one (1) year, provided, however, that this minimum vesting period shall not apply to (a) early vesting by reason of death or Change in Control, or (b) any Awards granted up to a maximum of five percent (5%) of the Shares available for issuance under the Plan. An
2019 Proxy Statement C-13 | ||||
EXHIBIT C | ||
Award made to a Non-employee Director with a vesting period at least equal to the period from the annual shareholders meeting at which the Award is granted to the next annual shareholders meeting shall be considered to have a vesting period of at least one (1) year. For the avoidance of doubt, any Awards that cease to be subject to a risk of forfeiture upon Retirement, involuntary termination, or another event, but that are not paid before the original vesting period of at least one (1) year has elapsed, shall be considered to be subject to a vesting period of at least one (1) year for purposes of this paragraph.
ARTICLE 14 DIVIDENDS AND DIVIDEND EQUIVALENTS
Except for Options and SARs, the Committee may grant Dividend Equivalents to a Participant based on the dividends declared on Shares that are subject to any Award granted to the Participant, with such Dividend Equivalents credited to the Participant as of the applicable dividend payment dates that occur during a period determined by the Committee. Dividend Equivalents shall be converted to and paid in cash or additional Shares or Awards by such formula and at such time and subject to such limitations as may be determined by the Committee. Notwithstanding the foregoing, dividends and Dividend Equivalents with respect to any Award shall be subject to the same vesting and, if applicable, performance conditions as the underlying Award and shall be paid to a Participant at the same time as the underlying Award.
ARTICLE 15 TRANSFERABILITY OF AWARDS AND SHARES
15.1 Transferability of Awards. Except as provided in Section 15.2, during a Participants lifetime, Options and SARs shall be exercisable only by the Participant personally, or, in the event of legal incompetence of the Participant, by the Participants duly appointed legal guardian. Awards shall not be transferable other than by will or the laws of descent and distribution or, if permitted by the Plan Administrator and in the manner specified by the Plan Administrator, by designation of a death beneficiary; and any purported transfer in violation of this Section 15.1 shall be null and void.
15.2 Committee Action. Except as provided in Section 7.7, the Committee may, in its discretion, determine that notwithstanding Section 15.1, any Awards shall be transferable, without compensation to the transferor, to and exercisable by such transferees, and subject to such terms and conditions as the Committee may deem appropriate; provided, however, no Award may be transferred for value without shareholder approval.
15.3 Restrictions on Share Transferability. The Committee may impose such restrictions on any Shares acquired by a Participant under the Plan as it may deem advisable, including, without limitation, minimum holding period requirements, restrictions under applicable federal securities laws, under the requirements of any stock exchange or market upon which such Shares are then listed or traded or under any blue sky or state securities laws applicable to such Shares.
15.4 Transferability after Death of a Participant. For the purpose of exercising Options or Stock Appreciation Rights after the death of the Participant:
(a) the individuals to whom the Options or Stock Appreciation Rights have been transferred pursuant to Section 15.1 shall have the privilege of exercising remaining Options, Stock Appreciation Rights or parts thereof, whether or not exercisable on the date of death of such Participant, at any time prior to the expiration date of the Options or Stock Appreciation Rights; and
(b) the duly appointed executors and administrators of the estate of the deceased Participant shall have the same rights and obligations with respect to the Options and Stock Appreciation Rights as legatees or distributees would have after distribution to them from the Participants estate.
ARTICLE 16 TERMINATION OF EMPLOYMENT OR TERMINATION OF DIRECTORSHIP
16.1 Effect of Termination of Employment or Directorship Generally. Each Award Agreement evidencing the grant of an Award shall provide for the following:
(a) The extent to which a Participant shall vest in or forfeit such Award following the Participants Termination of Employment or Termination of Directorship, as applicable.
(b) With respect to an Award in the form of an Option or SAR, the extent to which a Participant shall have the right to exercise the Option or SAR following the Participants Termination of Employment or Termination of Directorship, as applicable.
C-14 The Procter & Gamble Company | ||
EXHIBIT C | ||
The foregoing provisions shall be determined in the sole discretion of the Committee, shall be included in each Award Agreement entered into with each Participant, need not be uniform among all Award Agreements and may reflect distinctions based on the reasons for termination.
16.2 Effect of Termination of Employment for Cause. In addition to the forfeiture events specified in the Award Agreements as authorized by Section 16.1 above, a Participants Termination of Employment or Directorship for Cause shall result in the forfeiture of the Participants outstanding Awards in accordance with the following:
(a) Any outstanding and non-vested Options, SARs, Restricted Stock, RSUs, Performance Stock Units, Cash-Based Awards and Other Stock-Based Awards granted to the Participant shall be forfeited as of the Participants Termination of Employment or Directorship; and
(b) Any vested and unexercised Options and SARs, vested but not settled RSUs, earned but not settled Performance Stock Units, and earned and/or vested Cash-Based Awards and Other Stock-Based Awards granted to the Participant shall be forfeited as of the Participants Termination of Employment or Directorship.
ARTICLE 17 EFFECT OF A CHANGE IN CONTROL
Notwithstanding any other provision of this Plan to the contrary, the provisions of this Article 17 shall apply in the event of a Change in Control:
17.1 Awards Assumed by Successor. Upon the occurrence of a Change in Control, any Award granted under the Plan that is Assumed (as defined in Section 17.2 below) by the entity effecting the Change in Control shall vest and be exercisable, if applicable, in accordance with the terms of the original grant unless, during the two (2) year period commencing on the date of the Change in Control:
(a) a Participants employment or directorship is involuntarily terminated for reasons other than for Cause; or,
(b) a Participant who is an Employee terminates his or her employment for Good Reason.
If clause (a) or (b) applies, the Award shall become fully vested and exercisable, if applicable, and any restrictions that apply to the Award shall lapse, and any performance-based Award shall be deemed to be satisfied based on actual performance through the date of the Participants termination if such performance is determinable in the judgement of the Committee, and based on target level performance if actual performance is not determinable. Notwithstanding the foregoing, with respect to any Award that is subject to Code Section 409A, if the Change in Control is not also a change in control event within the meaning of Section 409A , the payment shall be made on the date payment would have been made had the Termination of Employment or Termination of Directorship not occurred. For purposes of this Section 17.1, a Termination of Employment for Good Reason shall not be considered to be for Good Reason unless:
(a) the Participant has provided the Company with a written notice of his or her intent to terminate employment for Good Reason within sixty (60) days of the Participant becoming aware of the circumstances giving rise to Good Reason; and
(b) the Participant allows the Company thirty (30) days to remedy such circumstances to the extent curable.
17.2 Assumed Awards Defined. For purposes of this Article 17, an Award shall be considered assumed (Assumed) if each of the following conditions are met:
(a) Options and SARs are converted into a replacement Award in a manner that complies with Code Section 409A;
(b) RSUs and Restricted Stock are converted into a replacement Award covering a number of shares of the entity effecting the Change in Control (or a successor or parent corporation), as determined in a manner substantially similar to the treatment of an equal number of Shares covered by the Award; provided that to the extent that any portion of the consideration received by holders of Shares in the Change in Control transaction is not in the form of the common stock of such entity (or a successor or parent corporation), the number of shares covered by the replacement Award shall be based on the average of the high and low selling prices of the common stock of such entity (or a successor or parent corporation) on the established stock exchange on the trading day immediately preceding the date of the Change in Control;
2019 Proxy Statement C-15 | ||||
EXHIBIT C | ||
(c) the replacement Award contains provisions for scheduled vesting, treatment on Termination of Employment or Termination of Directorship (including the definitions of Cause and Good Reason), and, if applicable, performance measures and associated target levels and payout factors that are no less favorable to the Participant than the underlying Award being replaced, and all other terms of the replacement Award (other than the security and number of shares represented by the replacement Award) are substantially similar to the underlying Award; and
(d) the security represented by the replacement Award is of a class that is publicly held and widely traded on an established stock exchange.
17.3 Awards not Assumed by Successor
(a) Upon the occurrence of a Change in Control, Awards under the Plan that are not Assumed by the person(s) or entity(s) effecting the Change in Control shall become fully vested and exercisable on the date of the Change in Control, any restrictions that apply to such Awards shall lapse, and any performance-based Award shall be deemed to be satisfied based on actual performance through the date of the Change in Control if such performance is determinable in the judgement of the Committee, and based on target level performance if actual performance is not determinable. Payment with respect to such Awards shall be made as follows:
(i) For each Option and SAR, the Participant shall receive a payment equal to the difference between the consideration (consisting of cash or other property, including securities of a successor or parent corporation) received by holders of Shares in the Change in Control transaction and the exercise price of the applicable Option or SAR, if such difference is positive. Such payment shall be made in the same form as the consideration received by holders of Shares. Any Options or SARs with an exercise price that is higher than the per share consideration received by holders of Shares in connection with the Change in Control shall be cancelled for no additional consideration.
(ii) For each Share of Restricted Stock, RSU, or Performance Stock Unit, the Participant shall receive the consideration (consisting of cash or other property, including securities of a successor or parent corporation) that such Participant would have received in the Change in Control transaction had he or she been, immediately prior to such transaction, a holder of the number of Shares equal to the number of Shares covered by the Restricted Stock, RSUs, or Performance Stock Units (based on actual performance through the date of the Change in Control if such performance is determinable in the judgement of the Committee, and based on target level performance if actual performance is not determinable).
(b) The payments contemplated by clauses (a) (i) and (ii) of this Section 17.3 shall be made upon or as soon as practicable following the Change in Control, provided, however, that with respect to any Award that is subject to Code Section 409A, if the Change in Control is not also a change in control event within the meaning of Section 409A, the payment shall be made on the date payment would have been made had the Change in Control not occurred.
ARTICLE 18 RIGHTS OF PARTICIPANTS
18.1 Employment. Nothing in this Plan or an Award Agreement shall (a) interfere with or limit in any way the right of the Company or any Subsidiary to terminate any Participants employment with the Company or any Subsidiary at any time or for any reason not prohibited by law or (b) confer upon any Participant any right to continue his employment or service as a Director for any specified period of time. Neither an Award nor any benefits arising under this Plan shall constitute an employment contract with the Company or any Subsidiary and, accordingly, subject to Articles 3 and 19, this Plan and the benefits hereunder may be amended or terminated at any time in the sole and exclusive discretion of the Board without giving rise to any liability on the part of the Company, any Subsidiary, the Committee or the Board.
18.2 Participation. No individual shall have the right to be selected to receive an Award under this Plan, or, having been so selected, to be selected to receive a future Award.
18.3 Rights as a Shareholder. Except as otherwise provided herein, a Participant shall have none of the rights of a shareholder with respect to Shares covered by any Award until the Participant becomes the record holder of such Shares.
C-16 The Procter & Gamble Company | ||
EXHIBIT C | ||
ARTICLE 19 AMENDMENT AND TERMINATION
19.1 Amendment and Termination of the Plan and Awards.
(a) Subject to subparagraphs (b) and (c) of this Section 19.1 and Section 19.3 of the Plan, the Board or the Committee may at any time amend or terminate the Plan or amend or terminate any outstanding Award.
(b) Except as provided for in Section 4.5, the terms of an outstanding Award may not be amended, without prior shareholder approval, to:
(i) reduce the Option Price of an outstanding Option or to reduce the Grant Price of an outstanding SAR,
(ii) cancel an outstanding Option or SAR in exchange for other Options or SARs with an Option Price or Grant Price, as applicable, that is less than the Option Price of the cancelled Option or the Grant Price of the cancelled SAR, as applicable, or
(iii) cancel an outstanding Option with an Option Price that is less than the Fair Market Value of a Share on the date of cancellation or cancel an outstanding SAR with a Grant Price that is less than the Fair Market Value of a Share on the date of cancellation in exchange for cash or another Award.
(c) Notwithstanding the foregoing, no amendment of this Plan shall be made without shareholder approval if shareholder approval is required pursuant to rules promulgated by any stock exchange or quotation system on which Shares are listed or quoted or by applicable U.S. state corporate laws or regulations, applicable U.S. federal laws or regulations and the applicable laws of any foreign country or jurisdiction where Awards are, or will be, granted under the Plan.
19.2 Adjustment of Awards Upon the Occurrence of Certain Unusual or Nonrecurring Events. The Committee may make adjustments in the terms and conditions of, and the criteria included in, Awards in recognition of unusual or nonrecurring events (including, without limitation, the events described in Section 4.5) affecting the Company or the financial statements of the Company or of changes in applicable laws, regulations, or accounting principles, whenever the Committee determines that such adjustments are appropriate in order to prevent unintended dilution or enlargement of the benefits or potential benefits intended to be made available under this Plan. The determination of the Committee as to the foregoing adjustments, if any, shall be conclusive and binding on Participants under this Plan. By accepting an Award under this Plan, a Participant agrees to any adjustment to the Award made pursuant to this Section 19.2 without further consideration or action.
19.3 Awards Previously Granted. Notwithstanding any other provision of this Plan to the contrary, other than Sections 19.2, 19.4 and 21.15, no termination or amendment of this Plan or an Award Agreement shall adversely affect in any material way any Award previously granted under this Plan, without the written consent of the Participant holding such Award.
19.4 Amendment to Conform to Law. Notwithstanding any other provision of this Plan to the contrary, the Board or Committee may amend the Plan or an Award Agreement, to take effect retroactively or otherwise, as deemed necessary or advisable for the purpose of conforming the Plan or an Award Agreement to any law relating to plans of this or similar nature, and to the administrative regulations and rulings promulgated thereunder. By accepting an Award under this Plan, a Participant agrees to any amendment made pursuant to this Section 19.4 to the Plan and any Award without further consideration or action.
ARTICLE 20 TAX WITHHOLDING
20.1 Amount of Tax Withholding. The Company shall have the power and the right to deduct or withhold, or require a Participant to remit to the Company, the amount necessary to satisfy applicable federal, state and local tax withholding requirements, domestic or foreign, with respect to any taxable event arising as a result of this Plan, but in no event shall such deduction or withholding or remittance exceed the maximum statutory withholding requirements in the applicable jurisdiction.
20.2 Share Withholding. With respect to withholding required upon the exercise of Options or SARs, upon the lapse of restrictions on Restricted Stock, upon the settlement of Restricted Stock Units or Performance Stock Units, or any other taxable event arising as a result of an Award granted hereunder (collectively and individually referred to as a Share Payment) the Committee may choose to satisfy the withholding requirement, in whole or
2019 Proxy Statement C-17 | ||||
EXHIBIT C | ||
in part, by having the Company withhold from a Share Payment the number of Shares having a Fair Market Value on the date the withholding is to be determined equal to the amount necessary to satisfy applicable federal, state and local tax withholding requirements, domestic or foreign, with respect to any taxable event arising as a result of this Plan, but in no event shall such withholding exceed the maximum statutory withholding requirement in the applicable jurisdiction.
ARTICLE 21 GENERAL PROVISIONS
21.1 Legend. The certificates for Shares may include any legend that the Committee deems appropriate to reflect any restrictions on transfer of such Shares.
21.2 Gender and Number. Except where otherwise indicated by the context, any masculine term used herein also shall include the feminine, the plural shall include the singular, and the singular shall include the plural.
21.3 Severability. In the event any provision of this Plan shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of this Plan, and this Plan shall be construed and enforced as if the illegal or invalid provision had not been included.
21.4 Requirements of Law. The granting of Awards and the issuance of Shares under this Plan shall be subject to all applicable laws, rules and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.
21.5 Delivery of Title. The Company shall have no obligation to issue or deliver evidence of title for Shares issued under this Plan prior to:
(a) Obtaining any approvals from governmental agencies that the Company determines are necessary or advisable; and
(b) Completion of any registration or other qualification of the Shares under any applicable national or foreign law or ruling of any governmental body that the Company determines to be necessary or advisable.
21.6 Inability to Obtain Authority. The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Companys counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained.
21.7 Investment Representations. The Committee may require any individual receiving Shares pursuant to an Award under this Plan to represent and warrant in writing that the individual is acquiring the Shares for investment and without any present intention to sell or distribute such Shares.
21.8 Employees Based Outside of the United States. Notwithstanding any provision of this Plan to the contrary, in order to comply with the laws in other countries in which the Company or any Subsidiaries operate or have Employees or Directors, the Committee, in its sole discretion, shall have the power and authority to:
(a) Determine which Subsidiaries shall be covered by this Plan;
(b) Determine which Employees or Directors outside the United States are eligible to participate in this Plan;
(c) Modify the terms and conditions of any Award granted to Employees or Directors outside the United States to comply with applicable foreign laws;
(d) Establish sub-plans and modify exercise procedures and other terms and procedures, to the extent such actions may be necessary or advisable. Any sub-plans and modifications to Plan terms and procedures established under this Section 21.8 by the Committee shall be attached to this Plan document as appendices; and
(e) Take any action, before or after an Award is made, that it deems advisable to obtain approval or comply with any necessary local government regulatory exemptions or approvals.
Notwithstanding the above, the Committee may not take any actions hereunder, and no Awards shall be granted, that would violate applicable law.
C-18 The Procter & Gamble Company | ||
EXHIBIT C | ||
21.9 Uncertificated Shares. To the extent that this Plan provides for issuance of certificates to reflect the transfer of Shares, the transfer of such Shares may be effected on a non-certificated basis, to the extent not prohibited by applicable law or the rules of any stock exchange.
21.10 Unfunded Plan. Participants shall have no right, title or interest whatsoever in or to any investments that the Company or any Subsidiaries may make to aid it in meeting its obligations under this Plan. Nothing contained in this Plan, and no action taken pursuant to its provisions, shall create or be construed to create a trust of any kind, or a fiduciary relationship between the Company and any Participant, beneficiary, legal representative or any other individual. To the extent that any individual acquires a right to receive payments from the Company or any Subsidiary under this Plan, such right shall be no greater than the right of an unsecured general creditor of the Company or the Subsidiary, as the case may be. All payments to be made hereunder shall be paid from the general funds of the Company, or the Subsidiary, as the case may be, and no special or separate fund shall be established, and no segregation of assets shall be made to assure payment of such amounts except as expressly set forth in this Plan.
21.11 No Fractional Shares. No fractional Shares shall be issued or delivered pursuant to this Plan or any Award. The Committee shall determine whether cash, Awards or other property shall be issued or paid in lieu of fractional Shares or whether such fractional Shares or any rights thereto shall be forfeited or otherwise eliminated.
21.12 Retirement and Welfare Plans. Neither Awards made under this Plan nor Shares or cash paid pursuant to such Awards may be included as compensation for purposes of computing the benefits payable to any Participant under the Companys or any Subsidiarys retirement plans (both qualified and nonqualified) or welfare benefit plans unless such other plan expressly provides that such compensation shall be taken into account in computing a Participants benefit.
21.13 Deferred Compensation. It is intended that any Award under this Plan shall either be exempt from Code Section 409A or shall comply, in form and operation, with Code Section 409A. If a Participant is a specified employee as defined under Code Section 409A and the Participants Award is to be settled on account of the Participants separation from service (for reasons other than death) and such Award constitutes deferred compensation as defined under Code Section 409A, then any portion of the Participants Award that would otherwise be settled during the six-month period commencing on the Participants separation from service shall be settled as soon as practicable following the conclusion of the six-month period (or following the Participants death if it occurs during such six-month period). Any Awards that are subject to Code Section 409A shall be interpreted in a manner that complies with Code Section 409A.
21.14 Nonexclusivity of this Plan. The adoption of this Plan shall not be construed as creating any limitations on the power of the Board or Committee to adopt such other compensation arrangements as it may deem desirable for any Participant.
21.15 No Constraint on Corporate Action. Nothing in this Plan shall be construed to: (i) limit, impair, or otherwise affect the Companys or a Subsidiarys right or power to make adjustments, reclassifications, reorganizations or changes of its capital or business structure, or to merge or consolidate, or dissolve, liquidate, sell or transfer all or any part of its business or assets; or, (ii) limit the right or power of the Company or a Subsidiary to take any action that such entity deems to be necessary or appropriate.
21.16 Governing Law. The Plan and each Award Agreement shall be governed by the laws of the state of Ohio excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Plan to the substantive law of another jurisdiction. Any legal action related to this Plan or the Awards hereunder may be brought in any federal or state court located in Hamilton County, Ohio, USA, and by accepting an Award, the Participant agrees to accept the jurisdiction of these courts and consent to service of process from said courts solely for legal actions related to the Plan and any Awards.
21.17 Delivery and Execution of Electronic Documents. To the extent permitted by applicable law, the Company may (i) deliver by email or other electronic means (including posting on a website maintained by the Company or by a third party under contract with the Company) all documents relating to the Plan or any Award thereunder (including without limitation, prospectuses required by the Commission) and all other documents that the Company is required to deliver to its security holders (including without limitation, annual reports and proxy
2019 Proxy Statement C-19 | ||||
EXHIBIT C | ||
statements) and (ii) permit Participants to electronically execute applicable Plan documents (including, but not limited to, Award Agreements) in a manner prescribed to the Committee.
21.18 No Representations or Warranties Regarding Tax Effect. Notwithstanding any provision of the Plan to the contrary or any action taken by the Company, Subsidiaries, or the Board with respect to any income tax, social insurance, payroll tax, or other tax, the acceptance of an Award under the Plan represents the Participants acknowledgement that the ultimate liability for any such tax owed by the Participant is and remains the Participants responsibility, and that the Company makes no representations or warranties about the tax treatment of any Award, and does not commit to structure any aspect of the Award to reduce or eliminate a Participants tax liability, including without limitation, under Code Sections 409A and 457A.
21.19 Successors. All obligations of the Company under this Plan with respect to Awards granted hereunder shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.
C-20 The Procter & Gamble Company | ||
The Procter & Gamble Company General Offices
![]() |
|
![]()
|
|
SHAREOWNER SERVICES P.O. BOX 64945 ST. PAUL, MN 55164-0945 |
VOTE BY INTERNET - www.proxyvote.com Use the Internet to transmit your voting instructions anytime before 11:59 p.m. on October 7, 2019. Have your proxy/voting instruction card in hand when you access the web site and follow the instructions on the website.
VOTE BY PHONE - 1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions anytime before 11:59 p.m. on October 7, 2019. Have your proxy/voting instruction card in hand when you call and follow the instructions the vote voice provides you.
VOTE BY MAIL Mark, sign, and date your proxy/voting instruction card and return it in the postage-paid envelope we have provided, or return it to The Procter & Gamble Company, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.
SHAREHOLDER MEETING REGISTRATION: To vote and/or attend the meeting, go to the Register for Meeting link at www.proxyvote.com. |
|
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
|
E83226-P27939 | KEEP THIS PORTION FOR YOUR RECORDS |
|
THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. |
DETACH AND RETURN THIS PORTION ONLY |
THE PROCTER & GAMBLE COMPANY
|
||||||||||||||||||||||||||
Vote on Directors
|
||||||||||||||||||||||||||
The Board of Directors recommends a vote FOR the following action:
|
||||||||||||||||||||||||||
1. ELECTION OF DIRECTORS
|
||||||||||||||||||||||||||
Nominees:
1a. Francis S. Blake |
For
☐ |
Against
☐ |
Abstain
☐ |
|
For |
|
|
Against |
|
Abstain |
||||||||||||||||
1b. Angela F. Braly | ☐ | ☐ | ☐ |
1k. Margaret C. Whitman |
|
☐ |
|
|
☐ |
|
☐ |
|||||||||||||||
1c. Amy L. Chang |
☐ |
☐ |
☐ |
1l. Patricia A. Woertz |
|
|
☐ |
|
|
☐ |
|
☐ |
||||||||||||||
1d. Scott D. Cook |
☐ |
☐ |
☐ |
Vote on Proposals |
|
|||||||||||||||||||||
1e. Joseph Jimenez |
☐ |
☐ |
☐ |
The Board of Directors recommends a vote FOR the following proposals: |
||||||||||||||||||||||
1f. Terry J. Lundgren |
☐ |
☐ |
☐ |
2. Ratify Appointment of the Independent Registered Public Accounting Firm |
|
☐ |
|
|
☐ |
|
☐ |
|||||||||||||||
1g. Christine M. McCarthy |
☐ |
☐ |
☐ |
3. Advisory Vote to Approve the Companys Executive Compensation (the Say on Pay vote) |
|
☐ |
|
|
☐ |
|
☐ |
|||||||||||||||
1h. W. James McNerney, Jr. |
☐ |
☐ |
☐ |
4. Approval of The Procter & Gamble 2019 Stock and Incentive Compensation Plan |
|
☐ |
|
|
☐ |
|
☐ |
|||||||||||||||
1i. Nelson Peltz |
☐ |
☐ |
☐ |
NOTE: Please sign exactly as name(s) appear(s) hereon. When signing as attorney, executor, administrator, trustee, or guardian, please give full title as such. |
||||||||||||||||||||||
1j. David S. Taylor |
☐ |
☐ |
☐ |
|||||||||||||||||||||||
Signature [PLEASE SIGN WITHIN BOX] | Date | Signature (Joint Owners) | Date | |||||||||||||||||||||||||||||
NOTICE OF ANNUAL MEETING
OF
SHAREHOLDERS
This is notice of the annual meeting of shareholders of The Procter & Gamble Company to be held on Tuesday, October 8, 2019 at 9:00 a.m. at the General Offices of the Procter & Gamble Company, 1 Procter & Gamble Plaza, Cincinnati, OH 45202.
In addition to reviewing the minutes of last years annual meeting and receiving reports of officers, the purposes of the meeting are listed on the voting portion of the proxy card which is located on the reverse side of this notice.
ADMISSION PROCEDURES: If you would like to attend the meeting in person, you may register for admission for yourself and one guest by:
● | Visiting www.proxyvote.com and following the instructions provided, or calling 1-844-318-0137. You will need the 16-digit control number included on your proxy card, voter instruction form, or notice. |
● | At the entrance to the meeting, we will verify your registration and ask to see valid photo identification for you and your guest (if applicable), such as a drivers license or passport. |
If you do not register for admission in advance, we will request to see your photo identification at the entrance to the meeting. We will then determine if you owned common stock on the record date by:
● | Verifying your name and stock ownership against our list of registered shareholders; or |
● | Asking to review evidence of your stock ownership as of August 9, 2019, such as your brokerage statement. You must bring such evidence with you in order to be admitted to the meeting. If you are acting as a proxy, we will need to review a valid written legal proxy signed by the owner of the common stock granting you the required authority to vote the owners shares. |
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:
The Notice and Proxy Statement and Annual Report are available at www.proxyvote.com.
E83227-P27939
|
THE PROCTER & GAMBLE COMPANY
SHAREHOLDERS PROXY AND CONFIDENTIAL VOTING INSTRUCTION CARD Annual Meeting of Shareholders Tuesday, October 8, 2019
With respect to any shares of Common Stock held by the undersigned directly or via the Companys Direct Stock Purchase Plan, the undersigned hereby appoints Angela F. Braly, W. James McNerney, Jr., and David S. Taylor (the Proxy Committee), and each of them, as proxies to attend the annual meeting of shareholders of the Company to be held on Tuesday, October 8, 2019, at 9:00 a.m. in Cincinnati, Ohio and any adjournment thereof and vote all shares held by or for the benefit of the undersigned as indicated on the reverse side of this card for the election of Directors and on any shareholder and Board of Directors proposals listed. If you sign and return this card without marking, this proxy card will be treated as being FOR the election of Directors, and FOR the recommendations of the Board of Directors on items 2, 3, and 4.
With respect to any shares of Common Stock, Series A ESOP Convertible Class A Preferred Stock, and Series B ESOP Convertible Class A Preferred Stock that are allocated to an account for you as a participant in any of the following plans The Procter & Gamble Profit Sharing Trust and Employee Stock Ownership Plan, The Procter & Gamble Savings Plan, The Gillette Company Employee Stock Ownership Plan, The Procter & Gamble Commercial Company Employees Savings Plan, and/or The Profit Sharing Retirement Plan of The Procter & Gamble Commercial Company (the NA Plans), the undersigned hereby instructs the respective plan fiduciaries to vote such shares as indicated on the reverse side of this card for the election of Directors and on any shareholder and Board of Directors proposals listed. The shares of Stock will be voted as follows, unless otherwise required by the Employee Retirement Income Security Act of 1974, as amended. The respective plan fiduciaries will vote the shares of Stock allocated to your accounts in the respective NA Plans as indicated on the reverse side of this card for the election of Directors and on the Board of Directors and any shareholder proposals listed. If the Companys proxy tabulator does not timely receive your votes or your votes are not properly signed and executed, the respective plan fiduciaries will vote the shares of Stock allocated to your accounts in the respective NA Plans in direct proportion to the voting of the shares of the same Class of Stock with respect to each plan for which the Companys proxy tabulator timely received properly signed and executed voting instructions. For the Procter & Gamble Profit Sharing Trust and Employee Stock Ownership Plan, the plan fiduciaries also will vote shares of Stock that are not allocated to any accounts in the same manner as shares of Stock for which the Companys proxy tabulator did not timely receive properly signed and executed voting instructions.
If other matters properly come before the meeting, the Proxy Committee in its discretion will vote all shares of Stock with respect to such matters.
This proxy/voting instruction card is solicited jointly by the Board of Directors of the Company and the respective plan fiduciaries identified above and pursuant to a separate Notice of Annual Meeting and Proxy Statement, receipt of which is hereby acknowledged. Votes should be received by the Companys proxy tabulator, Broadridge Financial Solutions, 51 Mercedes Way, Edgewood, NY 11717 by 11:59 p.m. ET on Monday, October 7, 2019, for shares of Common Stock held directly by you or via the Companys Direct Stock Purchase Plan to be voted by the Proxy Committee and by 4:00 p.m. ET on Friday, October 4, 2019 for shares of Company Stock allocated to your accounts in the respective NA Plans to be voted by the respective plan fiduciaries. Broadridge will report separately to the Proxy Committee and to the respective plan fiduciaries as to proxies received and voting instructions provided, respectively. Individual proxy and voting instructions will be kept confidential by Broadridge and not provided to the Company.
|
|||||||